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Foreword: The present doctorate thesis in Biomaterials was formally 
started at the Laboratory of Bioactive Polymeric Materials for Biomedical 
and Environmental Application (BIOlab), at the University of Pisa, from 
January to September 2010. 
After 9 months spent at the BIOlab, the opportunity to continue the PhD 
as an external candidate at the Novartis Vaccines and Diagnostics 
came, on a topic of interest for the Biomaterials Doctorate Course. 
Hence, it was decided also with the consensus of the Tutor & Supervisor 
to continue the undertaken Doctorate Course as an external candidate 
without the Institutional Grant originally supplied by the University of 
Pisa and with the Thesis work plan accepted and endorsed by the 
Company itself. 
Therefore the thesis is consisting substantially in two parts: the first 
minor part is a study aiming at the development of a polymeric product 
suitable for the formulation of nanoparticle drug delivery systems; the 
second part, upon the consensus of the Supervisor and Tutor, focused 
on studies on raw material of biologic origin for the improvement of 
fermentation bioprocesses. 
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Chapter 1 
Aim of the work 
The research carried out within the first part of this  Doctorate Thesis 
project is focused on the development of polymeric materials  suitable 
for the development of a nanocarrier system based on a Poly(lactic acid. 
co – ethyleneglycol) diblock copolymers suitable for biomedical use.  
Polymers were synthesized by ring opening polymerization of L-lactide 
by means of an hydroxyl end-capped methoxy-PEG sample having Mw 
5kDa and DPn=115. Polymerization reaction was performed both in bulk 
and solution (toluene) obtaining 6 g  of product  characterized by a PLA 
molar mass equal to 4315 Da and 4186 Da of PLA block respectively. 
Toxicity evaluated by WST-1 assay and cell morphology test performed 
on balb/3T3 clone A31 cell line demonstrated how at 1 and 5 mg/ml 
concentration polymers are not toxic, while toxicity increases at 10 
mg/ml. This system was intended for the development of  drug delivery 
systems suitable to be used for different purposes and which could allow 
overcoming the resistance towards the conventional chemotherapeutic 
treatments that characterize many solid tumors. 
 
 
 
10 
 
Sergio Pirato – PhD Thesis 
 
1. Introduction 
Nanotechnology development, in recent years, has offered a wide 
potential in cancer treatment overcoming the systemic toxicity of 
conventional anti-cancer treatments. 
Present-day chemotherapy is associated with severe side effect caused 
by drug-induced action on healthy tissues; in addition, in the process of 
chemotherapy cells become resistant to the active chemotherapeutics 
agents [1].  
Chemo-resistance, in tumors, can be due to the over-expression of the 
MDR1 gene, which is involved in the extracellular extrusion of the 
various drugs delivered to the cells and is the principal cause of 
treatments failure. Because of the heterogeneity of the tumors and their 
localization, a versatile and well-targeted anticancer system is required. 
Transient and stable RNAi strategies were applied to overcome 
MDR1/P-gp-mediated MDR in different in vitro models derived from 
various neoplastic tissue 1. 
Although conventional radio- and chemo- therapies are quite efficient, 
newer strategies aim to overcome the barriers given by the multidrug 
resistance 3. 
This function can be exploited by targeting a drug delivery system to the 
desired tissue. One of the targeting strategies is to use nanoparticles as 
the transferring carrier to encapsulate different agents, including plasmid 
DNA, proteins, and low molecular weight compounds. Then different 
targeting moieties are put on the surface of the nanoparticles, which are 
then physiochemically or biologically directed to the targeted lesions 
where they can achieve relatively high concentrations 
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Poly(L-lactic acid) (PLLA), in its crystalline form, is one of the best 
known piezoelectric polymer, while amorphous PLLA exhibit little, if any, 
piezoelectric behavior 4. Poly(lactic acid) (PLA) (Fig. 1) has been 
widely used in the formulation of (NPs) owing to its excellent 
biocompatibility, biodegradability and high encapsulation capability for 
hydrophobic drugs, being also approved by FDA for biomedical use.  
 
 
 
Fig. 1: Schematic structure of L-Lactide 
 
However, uptake of such naked NPs by the reticuloendothelial system 
after intravascular administration presented a major problem for 
achieving effective targeting to specific sites in the body other than liver 
and spleen [5]. Therefore, the design of long-circulating NPs or stealth 
NPs has emerged as an attempt to escape recognition by phagocytic 
cells of the blood. The most commonly used strategy for designing 
stealth NPs is reliant upon introducing flexible hydrophilic coat onto 
hydrophobic surfaces, shielding them against plasma protein adsorption, 
which is the first step of particle clearance mechanism by blood 
phagocytes.  
Polyethyleneglycol (PEG) (Fig. 2) has been widely used for modifying 
the surface in stealth-type carriers because the PEG chains on the 
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surfaces of these carriers act as a steric barrier and reduce interaction 
with opsonins and cells of the mononuclear phagocyte system; as a 
result, the carriers remain in the blood circulation for a prolonged 
duration.  
 
 
Fig. 2: Schematic representation of PEG  
 
Covalently grafted PEG strategy was proven stable and more successful 
than physical adsorption of PEG containing surfactants onto NPs 
surface. Generally, covalent copolymers of PLA (A) and PEG (B) can be 
divided into single-sided grafted defined as grafted or diblock copolymer 
(A–B) and double-sided grafted denoted as triblock copolymer (A–B–A) 
or multiblock copolymer. Many attempts have been made in the past to 
fabricate NPs using diblock copolymers of either PLA–PEG or 
poly(lactic-co-glycolic acid) PLGA–PEG [6,7]. 
These stealth-type (long-circulating) carriers show preferential 
accumulation in tumors and sites of inflammation because of the 
enhanced permeability and retention (EPR) effect (Fig. 3) [8]. 
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Fig. 3: Schematic representation of the enhanced permeability and retention 
effect at level of tumors due to the wider space of endothelial cell junctions. 
 
PEG-PLA nanoparticles have been widely used for several purposes 
such as to develop strategy for anti-thrombotic therapy, expressing 
EGFP-EGF1 fusion protein. This anti-thrombotic drug delivery system 
takes advantage of the TF-targeting property of EGF1 peptide [9]. 
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2. Materials and Methods 
Materials.  
Methoxy-terminated mPEG (MPEG-Mw 5000) and L-Lactide were 
purchased from Purac-Biochem (Amsterdam, NL). Stannous octanoate 
[Sn(Oct)2] was purchased from Sigma/Aldrich. All solvents used were 
commercially available (Carlo Erba, Milan, Italy). 
 
Synthesis of mPEG-PLA diblock copolymer. 
Before being used, L-Lactide was re-crystallized twice in order to 
remove impurities eventually present in the starting raw material: 10 g. 
of L-lactide were dissolved in 4 ml of ethyl acetate at 80°C in oil bath, 
filtered on paper, slowly cooled down at room temperature and finally 
washed with cooled ethyl acetate. Solvent was then removed under 
vacuum overnight.    
Polymerization reaction was performed in toluene previously distilled 
under nitrogen at 120°C in order to remove water residuals: 5 g. of 
mPEG were dissolved in 50 ml of toluene and warmed up to 110°C. 
Then, 4,7 g of L-lactide and 5 μl of stannous octanoate were added. 
Reaction was carried out for 24 h under nitrogen atmosphere.  
The same reaction was also performed in bulk by distilling all the toluene 
and then adding L-lactide and stannous octanoate. Reaction occurred at 
150°C for 3 h under nitrogen.   
 
Purification of PLA-PEG diblock copolymer. 
Neo-synthesized polymer was dissolved in 20 ml of dichloromethane 
(DCM) and dripped in continuously stirred diethyl ether (10:1 with DCM) 
in ice bath. When the agitation was stopped, the polymer was 
   15 
 
Sergio Pirato – PhD Thesis 
 
precipitated. mPEG-PLA copolymer was filtered on paper, washed three 
times with fresh diethyl ether, and solvents residuals removed under 
vacuum for 24 h. 
The final amount of obtained copolymer was  6 g in both cases. Both  
samples were analyzed by FT-IR and H1-NMR. 
 
Polymers toxicity assessment. 
A colorimetric assay (WST-1) for the quantification of cell proliferation 
and cell viability, was used to assess polymer toxicity.  
A subconfluent monolayer of balb/3T3 clone A31 cell line was washed 
with Dulbecco’s PBS 1X (10 ml.), after medium removal, in order to 
remove serum protein which inhibits trypsin. 
Then the monolayer was treated with 500µl of a 0,25 % trypsin 1 mM 
EDTA solution and incubated 5’ at 37 °C to allow the proteolytic activity 
of trypsin toward the collagen fibers of the extracellular matrix thus 
allowing cell solubilization. Cells were then re-suspended in 10 ml of 
new medium. 20 µl of the re-suspended cell solution were used to count 
the cells number through a Burker cell counting camera. 
A stock solution of 3,5 x 103 cell per 100 µl of medium was prepared and 
100 µl were added into each well (not for the blank line). Plates were 
incubated for 24 h at 37 °C 5% CO2. 
100 mg of each copolymer was subjected to UV treatment for 
sterilization and dissolved into 10 ml of medium to get a final 
concentration of 10 mg/ml (stock solution). 
Serial dilutions were made from the stock solution from 10mg/ml to 1 
mg/ml and 100 µl of each was added to the wells after old medium 
removal. For the control and the blank new medium without polymer 
were added. Plates were incubated for further 24 h at 37 °C 5% CO2.   
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Optical microscopy observation revealed that the polymer suspension 
employed to incubate the cells create a deposit onto the cell monolayer. 
It was decided then to remove the medium containing the polymer and 
to proceed with the WST-1 assay. 
After one hour of incubation (37 °C, 5% CO2) 10 µl of WST-1 solution 
was added to each well and incubated again 4 h as in previous 
conditions. After 4 h of incubation, absorbance of each plate was 
acquired at 450 nm using 620 nm as reference wavelength. All 
percentage measurements were blank subtracted and normalized with 
respect to the control. 
 
Cell morphology evaluation. 
In order to investigate cells morphology 50 ml of a 4% w/v 
paraformaldehyde solution in PBS 1X pH 7.4 was prepared and used to 
fix the cells onto the cover slip. 
20 ml of a TRITON 0,2% solution in PBS 1X was prepared to 
permeabilize cell membrane thus allowing probes entrance into the cell. 
DAPI (3 µl/ml) and Phalloidin-Alexa 488 (5 µl/ml) were added into 1,5 ml 
of a PBS 1X solution, to label the cellular structures.  
Cells grown on glass coverslips and treated with the different 
concentrations of the polymers, washed with PBS 1X (1ml) to remove 
the medium and then incubated with 1 ml of paraformaldehyde (45’). 
Cells were then washed twice with 1 ml of PBS 1X and treated with 1 ml 
of TRITON 0,2% solution for 15’ to permeabilize cell membrane. After 2 
further washing with PBS 1X, 100 µl of PBS solution containing 
fluorescent probes was applied onto the coverslips obtaining a complete 
coverage and incubated 45’ at room temperature and protected from 
light. Coverslips were finally washed two times with PBS and mounted 
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on glass slides. Once dry, coverslips where fixed onto the glass slide 
using enamel. Glass slides were stored at 4°C in the dark. 
CLSM measurements were performed at 20X and 60X magnification.  
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3. Results and discussion 
3.1 Synthesis and characterization of PEG-PLA copolymer 
L-lactide, once re-crystallized was analyzed by H1-NMR (Fig. 4) in order 
to evaluate molecular integrity since, if spontaneously hydrolyzed  would 
be not anymore suitable for polymerization reaction.   
The absence of 12 ppm band indicated that no hydrolysis occurred and 
that the monomer was suitable for the polymerization reaction for the 
production of mPEG-PLA copolymer.  
 
 
Fig. 4: H1-NMR analysis of the re-crystallized L-lactide 
 
The obtained mPEG-PLA copolymers (toluene solution and bulk 
produced) were analyzed by FT-IR spectroscopy in order verify the 
presence of  the PLA chain (Fig. 5). 3500 cm-1 band indicates the 
stretching frequency of the terminal OH group of the PLA chain, and the 
1759 cm-1 indicates the stretching frequency of the C=O group within the 
PLA chain. PEG presence was confirmed by the band at 1100 cm-1 as 
part of the CH2-CH2-O bonds. 
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Fig. 5: FT-IR analysis of both toluene solution (left) and bulk (right) m PEG-
PLA produced copolymer. 
H1-NMR measurement (Fig. 6) was performed on both the prepared 
products. Band at 3,8 ppm refers to mPEG contribution that was 
comparable in both type of preparations. Band at 1,6 ppm refers to the 
CH3 group of the lactide, which contribution is slightly different between 
toluene solution and bulk polymerizations. The obtained polymer 
samples showed following PLA content: 
- PLA-PEG 5000:4186 (toluene soluzione) 
- PLA-PEG 5000:4315 (bulk) 
 
Fig. 6: H1-NMR analysis of both toluene solution (left) and bulk (right) m PEG-
PLA produced copolymer.  
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3.2 Toxicity evaluation on balb/3T3 (Clone A31) cells 
A colorimetric assay for the quantification of cell proliferation and cell 
viability, based on the cleavage of the tetrazolium salt WST-1 by 
mitochondrial dehydrogenases in viable cells, was used to assess 
polymer toxicity (Fig. 7).  
 
 
Fig. 7: The tetrazolium salt will be cleaved to formazan by cellular 
mitochondrial dehydrogenases active only in viable cells. The formazan 
concentration is directly proportional to the number of living cells and can be 
monitored by its absorption spectrum (420-480 nm) and its maximum (440 
nm). 
 
Bulk polymerization product showed good cytocompatibility within the 
range of polymer concentration 1 and 8 mg/ml. At higher concentration a 
decrease in cell viability was observed even if the value was never 
below 50%.  
For toluene solution polymer the materials appeared fully cytocompatible 
for all the range of concentrations tested. This preliminary indication 
suggests a full compatibility of the prepared polymer. 
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Fig. 8: Polymers toxicity evaluation on assessed on balb/3T3 (Clone A31)  by 
the WST-1 test. 
 
3.3  DAPI-Phalloidin morphology evaluation. 
The effect of the prepared polymer on cell viability and morphology was 
investigated was investigated also by using confocal laser microscopy 
technique: two fluorescent probes labeling differentially cytoplasm 
(green) and nucleus (blue) were used.  
DAPI or 4',6-diamidino-2-phenylindole is a fluorescent probe that binds 
strongly to DNA marking the nucleus of the cell. Since DAPI will pass 
through an intact cell membrane, it may be used to stain both live and 
fixed cells. For fluorescence microscopy, DAPI is excited with ultraviolet 
light. When bound to double-stranded DNA its absorption maximum is at 
358 nm and its emission maximum is at 461 nm. 
Phalloidin is a toxin that strongly binds to the actin fibers of cell 
cytoskeleton. In our study phalloidin conjugated with a Alexa 488 (a 
green fluorescent probe) was employed to stain and visualize the actin 
components of cell cytoskeleton. Phalloidin-Alexa 488 has an absorption 
maximum at 494 nm and emission maximum of 521 nm. 
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Fig. 9: Morphology DAPI-Phalloidin test of balb/3T3 (Clone A31) cells  of 
polymers at different concentrations (1, 5 and 10 mg/ml). Confocal Laser 
Microscopy performed at 20X magnification. 
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Fig. 10: Morphology DAPI-Phalloidin test of balb/3T3 (Clone A31) cells  of 
polymers at different concentrations (1, 5 and 10 mg/ml). Confocal Laser 
Microscopy performed at 20X magnification 
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Results showed an increase in cell proliferation and number when 
decreasing the polymer concentration for both toluene solution and bulk 
synthesized polymers (Fig. 9 and Fig. 10). 
At 10 mg/ml polymer concentration a substantial inhibition of the cell 
growth (20X magnification), and an altered cellular morphology (60X 
magnification) is detected, due to the high polymer concentration.  
5 and 1 mg/ml panels show a similar cell growth (20X magnification) that 
is comparable with the control and the classical fibroblasts morphology 
is preserved as well (60X magnification). 
 
4. Conclusions 
Nanocarriers offer unique possibilities to overcome cellular barriers in 
order to improve the delivery of various drugs and drug candidates, 
including the promising therapeutic biomacromolecules (i.e., nucleic 
acids, proteins). Polymeric nanoparticles are generally based either on 
synthetic biodegradable polymers like the poly(lactic acid) (PLA). 
Polyethyleneglycol (PEG) is widely used to modify the surface of the 
stealth-type carriers in order to enhance its blood-circulating life. 
In this study a mPEG-PLA block copolymer suitable for nanocarrier 
formulation was developed. Toluene solution and bulk polymerization 
reaction were used to produce a two diblock copolymer samples 
characterized by a molar weight of 4186 and 4315 Mw of PLA and 5000 
Mw of PEG Methoxy terminated giving a comparable yield. 
Polymers were investigated in term of toxicity on balb/3T3 (Clone A31) 
cells providing comparable results for concentrations in the range of 5 
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mg/ml that is comparable to dextran (5 g/kg). Cells morphology 
evaluation confirmed the quantitative viability results. 
The planned activities relevant to the formulation of NPs loaded with 
anticancer drugs are at the present under investigation within the 
research group at the BIOlab involved in work-plans relevant to 
biomedical applications in targeted drug delivery area and in the 
fabrication of scaffolds of interest in Regenerative Medicine.  
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Chapter 2 
1. Introduction  
Industrial production of biopharmaceuticals must be considered at 
different levels: biological development (Screening and selection, 
mutation and strain maintenance), development and optimization of the 
fermentation process and transfer for large-scale production. For each 
individual product, process and facilities, suitable strategies have to be 
elaborated by a comprehensive and detailed process characterization, 
through the identification of the most relevant process parameters 
influencing product yield and quality. 
Several aspects and constrains, in addition to economic costs and 
benefit evaluation, must be taken into account when developing 
fermentation processes since there are several elements contributing to 
the safe manufacture of high quality products. These include the design 
and layout of manufacturing facilities, the raw materials used in the 
manufacturing process and the process itself. Downstream available 
process technologies have also to be considered when developing 
fermentation processes since the upstream manufacturing can influence 
the accomplishment of product recovery and purification. 
One important aspect is the existence of a regulatory framework, which 
assures the establishment and maintenance of the highest quality 
standards with regards to all aspects of manufacturing process. Each 
manufacturing process must be well characterized and submitted to the 
regulatory bodies that, after a comprehensive evaluation of product 
quality and effectiveness, license product marketing. In order to satisfy 
   29 
 
Sergio Pirato – PhD Thesis 
 
regulatory requirements, the timeline needed between product discovery 
and its approval for the market may vary from 7 to 15 years.  
 
1.1. History of fermentation and related 
biotechnology 
The term “fermentation” derives from the Latin word “fervere” which 
means, “to ferment.” Fermentation is an ancient process dating back 
thousands of years. It was the means by which bread, wine, beer, and 
cheese were made. Egyptians found that uncooked dough left standing 
became lighter and softer. They and the Romans discovered that yeast 
produced lighter and leavened bread. Around 4000 BC wine was made 
from grape juice through a fermentation process. Beer making by the 
ancients came about by the soaking of barley in water, probably a 
serendipitous by-product of bread making.  
The Chinese used micro-organisms in the production of yogurt, cheese, 
wine, vinegar, and different types of sauces. Cheese was made by 
storing milk in animal skins or bladders made from animal stomachs. 
The bacteria and enzymes present in these containers would cause 
separation of casein (milk protein) to form curd. Fermented rice, 
vegetables, and fruits were extensively used by Ecuadorians [1].  
The origins of microbiology (other than the general knowledge of 
fermented foods which existed worldwide since ancient times) can be 
traced back to the invention of the compound microscope in the late 
1500s. in 1680, using a microscope that magnified the diameter of each 
object 300-fold, the Dutch merchant Anton van Leeuwenhoek looked at 
yeasts and found them to consist of tiny spheroids. No connection was 
drawn between the existence of these tiny organisms and the well-
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known phenomenon of fermentation. The first solid evidence of the living 
nature of yeast appeared between 1837 and 1838 when three 
publications each of which independently concluded as a result of 
microscopic investigations that yeast was a living organism that 
reproduced by budding.  The debate was finally brought to an end by 
the great French chemist Louis Pasteur who, during the 1850s and 
1860s, in a series of classic investigations, proved conclusively that 
fermentation was initiated by living organisms. In 1857 Pasteur showed 
that living organisms cause lactic acid fermentation. In 1860 he 
demonstrated that bacteria cause souring in milk, a process formerly 
thought to be merely a chemical change, and his work in identifying the 
role of microorganisms in food spoilage led to the process of 
pasteurization. In 1877, working to improve the French brewing industry, 
Pasteur published his famous paper on fermentation, “Etudes sur la 
Biere”, which was translated into English in 1879 as Studies on 
Fermentation. He defined fermentation (incorrectly) as "Life without air," 
but correctly showed that specific types of microorganisms could cause 
specific types of fermentations and specific end products [2]. In 1877 the 
era of modern medical bacteriology began when Koch and Pasteur 
showed that the anthrax bacillus caused the infectious disease anthrax. 
This epic discovery led in 1880 to Pasteur's general germ theory of 
infectious disease, which postulated for the first time that each such 
disease was caused by a specific microorganism. Koch also made the 
very significant discovery of a method for isolating microorganisms in 
pure culture [3]. 
With advances in the science of microbiology and technologies like 
biotechnology, especially recombinant DNA technology, micro-
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organisms are exploited to produce a wide variety of products using 
fermentation. These include:  
• Dairy products: Cheese, yogurt [1,4]. 
• Beverages:  Beer, wine [1,4]. 
• Single Cell Proteins (SCP): SCPs are a cell monoculture of bacteria, 
fungi, and algae. Since the cells contain large amounts of protein, SCP 
is used as food or food supplement for humans and cattle. It is regarded 
as a cheap source of dietary protein and is produced from methanol and 
by-products of cheese production and paper making [1,4].  
• Antibiotics: Antibiotics are one of the most important compounds 
produced by fermentation. Alexander Fleming in 1929 was the first to 
discover “penicillin”, an antibiotic. Large numbers of antibiotics are being 
produced now by fermentation using various bacteria and fungi [5].  
• Chemicals: Citric and acetic acid, amino acids, enzymes, vitamins etc. 
[1,4].   
• Fuels: Ethanol, methanol and methane [6].  
In fact, pharmaceutical biotechnology has now become one of the key 
industries. Recombinant DNA technologies have entered drug discovery 
and all fields in the development and manufacture of therapeutic 
proteins and nucleotides. Biotechnology has a major impact on 
pharmaceutical industry because recent advances in recombinant 
protein chemistry, vaccine production, and diagnostics have and will 
revolutionize the treatment paradigms for many serious and unmet 
diseases [7].  
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Year Historic event 
6000bc Bread-making (involving yeast fermentation) 
3000bc Moldy soybean curd used to treat skin infections in China 
2500bc Malting of barley, fermentation of beer in Egypt 
1680 
Anton van Leeuwenhoek looked at yeast and found them to 
consist of tiny spheroids 
1797 
Jenner inoculates child with viral vaccine to protect him 
from smallpox 
1857 Pasteur proposes that microbes cause fermentation 
1900-
1920 
Ethanol, glycerol, acetone, and butanol produced 
commercially by large-scale fermentation 
1923 
Citric Acid fermentation plant using Aspergillum Niger by 
Charles Pfizer 
1928 Penicillin is discovered by Fleming 
1944 
Avery proves DNA as carrier of genetic information 
Waksman isolates streptomycin as antibiotic for 
tuberculosis 
1953 Structure elucidation of double helix of DNA 
1967 First protein sequencer is perfected 
1970 Discovery of restriction enzymes 
1973 
Cohen and Boyer produce first recombinant DNA in 
bacteria with restriction enzymes and ligases. 
1977 First expression of human protein in bacteria 
1980 US Patent for gene cloning to Cohen and Boyer 
1981 First transgenic animal 
1982 Insulin as first recombinant biotech drug approved by FDA 
1983 Invention of Polymerase Chain Reaction (PCR) 
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Year Historic event 
1986 
First recombinant vaccine for Hepatitis B (Recombivax 
HB®) 
1988 
First US Patent for genetically modified mouse 
(Onkomouse) 
1990 
Launching of the Human Genome Project 
First somatic gene therapy to cure ADA-SCID 
First transgenic cow produces human proteins in milk 
1994 Approval of DNAse for cystic fibrosis 
1997 First animal cloned from adult cell (Dolly) 
2000 Rough draft of the human genome is announced 
2002 
Draft version of the complete map of the human genome is 
published 
First oligonucleotide drug is approved by FDA 
2007 First complete individual, diploid human genome sequence 
2010 
Creation of a bacterial cell controlled by a chemically 
synthesized genome 
Tab. 1: Short timeline in pharmaceutical biotechnology. 
 
Before biotechnology had been intensively introduced to industrial 
research, developing costs of each drug had large impact on 
companies’ economy, taking more than 15 years to market 
authorization. About 75% of these costs were spent on failures. Using 
genomic technologies, there is a realistic chance of reducing companies’ 
costs of about 30%, largely as a result of efficacy gains. Significant 
savings not only of money but also of time by 15% are possible [8]. 
In 2010, Ventner et al. succeeded in creating a bacterial cell controlled 
by a chemically synthesized genome with expected phenotypic 
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properties and capable of continuous self-replication [9], paving the way 
for the creation of microorganisms with the desired characteristics that 
will lead to further industrial applications.   
 
1.2. Fermentation process: an overview 
The term fermentation denotes microbial cell (either wild type or 
recombinant) propagation and generation of products under either 
aerobic or anaerobic conditions. Metabolites are usually secreted from 
the inside of microbial cells to the surrounding medium and 
accumulation of the metabolite in the medium occurs. Fermentations are 
classified as type I, II, or III (Fig. 1) depending on the phase of cell 
metabolism in which the product occurs [10]: 
 
I. Fermentations (either aerobic or anaerobic) where the main 
product is the result of primary energy metabolism. The 
formation of these products matches with the glycolysis or 
citric acid pathways. The most common products are single 
cell product (SCP) for human food or animal feed, ethanol, 
glutamic acid, lysine and polysaccharides. 
II. Fermentations in which, even the product is part of the primary 
metabolism; there is a delay between cell growth (substrate 
consumption) and product accumulation. In this case, product 
is not directly obtained from oxidation of the carbon source. 
Most common products are citric acid or amino acids. 
III. In this case, product is accumulated independently from cell’s 
energy metabolism being not directly involved in glycolytic or 
citric acid cycle pathways. After an initial phase of substrate 
consumption and biomass production, cell growth is halted 
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and product accumulation occurs as part of secondary 
metabolism. Most common products of this type of 
fermentation are the antibiotics and extracellular enzymes. 
IV.  
 
Fig. 1: Schematic representation of the correlation among cell biomass, 
substrate and product accumulation in type I, II and III. 
 
As part of primary metabolism, microorganisms usually break down high 
molecular weight carbon and energy sources into small molecules, 
convert these to amino acids, nucleotides, vitamins, carbohydrates, and 
fatty acids, and finally build these basic materials into proteins, 
coenzymes, nucleic acids, polysaccharides and lipids used for growth. 
Metabolism must be coordinated to ensure that, at any particular 
moment, only the necessary enzymes, and the correct amount of each, 
are made. 
Thus, the cell does not normally overproduce metabolites, regardless of 
its environment, and this enables a species to compete efficiently with 
other forms of life and survive in nature [11]. Some of the important 
control mechanisms carrying out these modulating functions are 
substrate induction, feedback regulation, and nutritional regulation.  
36 
 
Sergio Pirato – PhD Thesis 
 
Many bacteria are able to regulate the expression of specialized gene 
sets in response to population density. This regulatory mechanism is 
commonly referred to as auto-induction (thru small diffusible signal 
molecule), quorum sensing, or population density-responsive gene 
regulation. Auto-inducer molecules are also involved in the induction of 
secondary metabolism like in the rifamycin production in Amycolatopsis 
mediterrane [12]. Modification and control of such mechanisms in 
certain wild-type microorganisms isolated from nature and/or 
intentionally modified in the laboratory allows the overproduction of 
certain primary and secondary metabolites. This is the essence of 
industrial fermentations [13]. 
 
1.2.1. Microbial growth When a microorganism is introduced into a 
nutrient medium that supports its growth, the inoculated culture will pass 
through a certain number of stages. When cultured in batch 
fermentations cell growth is always characterized by a constant behavior 
[14] that can be divided into 4 phases (Fig. 2): 
 
I. Lag phase: the organisms are adjusting to their environment. 
The proteins and enzymes necessary for energy production 
and binary fission are being produced and the ribosomes 
necessary for their production are also being synthesized. 
Population numbers are stagnant at this phase. 
II. Exponential phase: the population is most actively growing 
dividing at constant rate. This is represented as a linear line 
when plotted on a semi-log scale. This represents the 
exponential growth, which is characterized by a massive 
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consumption of the nutrients contained in the medium and, in 
case of aerobic fermentations, by a huge amount of oxygen 
request for ATP generation in primary metabolism. Growth 
rate is limited only by the bacteria's ability to process the 
substrate in case of nutrient excess.  
III. Stationary phase: new organisms are being produced at the 
same rate at which they are dying. This represents a sort of 
equilibrium between cell birth and cell death. The availability 
of nutrients is becoming limiting and the cells are scrambling 
to survive by making adjustments within the cell and oxygen 
demand drastically decreases. During this phase secondary 
metabolism is predominant.  
IV. Death phase: the organisms are dying more quickly than the new 
reproducing organisms. This is a shift away from the 
equilibrium described in stationary phase. Despite their best 
efforts, the cells cannot adapt to the harsh conditions 
described above and begin to lyses, deceasing the cell 
number. The population decreases exponentially similar to the 
linear nature of cell birth seen in log phage.  
Microbial growth is often monitored by sampling the culture and 
monitoring the optical density (light adsorption) at 590 nm. However, in 
the last years, many on-line measurements methods have been 
developed minimizing the contamination risks.  
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Fig. 2: The four phases of pure culture microbial growth in batch 
fermentations. 
 
Type I and type II fermentations (figure 1) are usually harvested, for 
product recovering, just before the stationary phase. Type III 
fermentations are harvested before the death phase since the product, 
part of secondary metabolism, occurs during stationary phase.  
Especially in case of protein products, harvest has to be performed 
before the death phase; cell death lead to protease release, which will 
cause proteins degradation [15,16].   
There are equations that can describe cell growth and product formation  
based on the exponential growth phases. The generation of cells (or cell 
mass) X is given by: 
X = X0 2
n 
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Where the initial cell mass is X0 and the number of generations by n. If 
the doubling of cell mass (n = 2) occurs over a time period td, then the 
growth rate is given by:  
µd = n / td 
Equations can be combined and the growth rate can be expressed as: 
µ = (ln (X / X0)) / td = (1 / X) (dX / dt) 
The slopes reported in the following figure (Fig. 3) correspond to specific 
growth rates for an initial population X0 of cells. Growth rate can provide 
several information on microbial behavior with respect to fermentation 
process changes such as temperature, dissolved oxygen, pH as well as 
on raw materials for metabolic studies [14].   
 
Fig. 3: Example of logarithmic plot of growth rate vs time . 
The goal, in a practical fermentation, is to maximize the amount of 
product obtained per unit volume of the fermentation vessel. This is 
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achieved in much fermentation when the lag and stationary phases are 
as short as possible, and the time course of the overall batch process 
coincides with the exponential growth phase. 
The correlation of cell population with the amount of product requires 
that yield coefficients (Y) can be defined as the ratio between increase 
in product (∆P) and the increase in biomass (∆X) [14]. 
 
1.2.2. Fermentation Methods Fermentations can be carried out in 
flasks, glass vessels and specially designed stainless-steel tanks. The 
upstream processing element of the manufacture of a batch of 
biopharmaceutical product begins with the use of a single ampoule of 
the working cell bank. This vial is used to inoculate a small volume of 
sterile media, with subsequent incubation under appropriate conditions. 
This describes the growth of laboratory-scale starter cultures of the 
producer cell line. This starter culture is, in turn, used to inoculate a 
production-scale starter culture that is used to inoculate the production-
scale bioreactor (Fig. 4). 
 
 
Fig. 4: Outline of the upstream processing stages involved in the production of 
a single batch of product. 
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Based on microbial oxygen requirement, fermentation can be divided in 
anaerobic and aerobic. 
Anaerobic fermentation is a method in which cells use to extract energy 
from carbohydrates when oxygen or other electron acceptors are not 
available in the surrounding environment. The process can follow the 
glycolysis as the next step in the breakdown of glucose and other 
sugars to produce molecules of adenosine triphosphate (ATP) that 
create an energy source for the cell. 
When running an anaerobic fermentation medium aeration is not 
required as well as the mixing device: the CO2 generated by the culture 
is enough to provide culture agitation. In the case of strictly obligated 
anaerobes strains, the air present in fermenter headspace has to be 
replaced with gases such as nitrogen, hydrogen or carbon dioxide. One 
of the most promising applications of anaerobic fermentation is the 
production of biofuels from a carbon source such as glycerol [17]. 
In aerobic fermentations is essential the right oxygen supply to the 
culture which must be provided by an adequate aeration of the medium 
and, in some cases, even by efficient mixing of the medium. Submerged 
fermentations are used to describe the cultivation of microorganisms in 
liquid nutrient broth. They are ideal for the growing of unicellular 
organisms such as bacteria, which must be provided with oxygen and 
adequate mixing.  Applying this growing technique to some filamentous 
fungi leads to a large number of difficulties due to the abundant viscosity 
reached by the culture broth. Solid state fermentation is used for these 
type of cultures. It consists in seeding a medium that is saturated with 
water but with little free-flowing water. The solid medium comprises both 
the substrate and the solid support on which the fermentation takes 
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place. The substrate used is generally composed of vegetal by-products 
such as beet pulp, wheat bran or other kinds of vegetal product [18].  
In turn, submerged fermentations can be divide in three types: 
Batch fermentations: are carried out in a closed system, where no new 
nutrients are added during the process. The bacteria grow and multiply 
undergoing through the above described phases: from the lag and log 
phases (with nutrients depletion) into the stationary phase. This 
eventually results in the bacteria entering the death phase mainly due to 
lack of nutrients or accumulation of toxic product. This type of 
fermentation offers a certain number of advantages, such as: minimized 
risk of possible contamination, easier mode of product recovery and 
enhanced substrate concentrations [19]. An example of batch 
fermentations is represented by citric acid fermentation by Aspergillum 
Niger [20]  
Fed-batch fermentations: This fermentation process is based on the 
feeding of a growth limiting nutrient substrate to a culture. The fed-batch 
strategy is typically used to reach a high cell density in the bioreactor. 
Depending on the working volumes, mostly, the feed solution is highly 
concentrated to avoid dilution of the bioreactor. The controlled addition 
of the nutrient directly affects the growth rate of the culture and helps to 
avoid overflow metabolism and oxygen limitation (anaerobiosis). After 
consumption of the substrate supplied with the starting medium, a 
continuous feed of this substrate is started [21].  
The use of fed-batch culture by the fermentation industry takes 
advantage of the fact that the concentration of the limiting substrate may 
be maintained at a very low level, thus, avoiding repressive effects of 
high substrate concentration [19]. 
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Saccharomyces Cerevisiae is industrially produced using the fed-batch 
technique so as to maintain the glucose at very low concentrations, 
maximizing the biomass yield and minimizing the production of ethanol 
[22]. Penicillin production is an example for the use of fed-batch in the 
production of a secondary metabolite. The fermentation is divided into 
two phases: the rapid-growth phase during which the culture grows at 
the maximum specific growth rate, and the slow-growth phase in which 
penicillin is produced. During the rapid-growth phase, an excess of 
glucose causes an accumulation of acid and a biomass oxygen demand 
greater than the aeration capacity of the fermenter. Glucose starvation 
may result in the organic nitrogen in the medium being used as a carbon 
source, resulting in a high pH and inadequate fermentation process. 
During the production phase, feeding rates should limit the growth rate 
and oxygen consumption such that a high rate of penicillin synthesis is 
achieved and sufficient dissolved oxygen is available in the medium 
[10]. 
Continuous fermentation: A continuous fermentation keeps nutrient 
concentration constant and number of bacteria constant by periodically 
removing some of the bacteria. This generally maintains the bacteria in 
the log or stationary phase, as there is no build up of toxins and no 
depletion of nutrients. New technologies are under development for fuel 
ethanol production by Saccharomyces Cerevisiae [23]. 
Regardless of the type of fermentation, there are some factors that are 
critical and govern submerged fermentation. These main factors are 
temperature, pH and dissolved oxygen tension (DOT) of a culture broth 
[10,24]: 
I) Temperature: Each fermentative process essentially requires 
optimum temperature for the growth of the microorganism, 
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which varies accordingly with the progressive stages of the 
entire process. Temperature remarkably influences the activity 
of enzymes and the effectiveness of microbial metabolism. It 
is, therefore, almost mandatory to closely monitor the range of 
temperature during fermentation in such a manner which 
would favorite cell growth appropriately. 
II) pH: Stability and operability of enzymes is also guided by the pH 
optimal conditions. Therefore, it is quite evident to sustain and 
maintain pH optima so as to accomplish the maximum growth 
rate of the specific organism in question. In other words, it is 
absolutely vital and necessary that not only the ‘pH profile in 
the course of fermentation alone’, but also the ‘enzyme 
production phase’ must be imposed as well as monitored in 
such a manner so as to achieve the maximum growth. 
III) Dissolved Oxygen Tension (DOT): In actual practice, the 
dissolved oxygen tension (DOT) may be maintained 
stringently by controlling three most important physical 
conditions, such as: adequate rate of aeration; agitation ratio 
and gas-phase pressure. It has been amply demonstrated that 
the ‘level of O2’ just lower than its critical concentration does 
affect the growth of microorganisms adversely. Therefore, it is 
very essential to maintain ‘appropriate aerobic condition’ in the 
growth culture medium. Interestingly, the desired level of O2 
predominantly in the submerged microbial cultures may be 
obtained by adopting the following methods, namely  (i) 
Enhancing the mass of O2 being provided to the bioreactor 
per unit time by increasing the ensuing rate of air supply to the 
bioreactor. (ii) Increasing the overpressure in the head-space 
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of the bioreactor; this lead to an increased oxygen transfer 
from the gas to the liquid phase. (iii) Increasing the rotational 
speed of the impellers, increasing the number of bubbles into 
the medium, that consequently increases the gas-liquid 
contact surface. 
As such, these factors need to be carefully set during the development 
of a fermentation process. However, there are other parameters that 
have to be monitored and controlled in a fermentation process 
(pressure, pCO2, exhaust line gasses). For this purpose, high-
performance bioreactors are equipped with a large number of in situ 
sensors, which allow precise monitoring and controlling many operating 
variables. 
One of the issues encountered during fermentation bioprocessing is the 
formation of foam from fermentation medium. Foam is the dispersion of 
a gas in a continuous liquid phase, and thus foam dispersions possess 
bulk densities closer to that of a gas rather than a liquid  [25]. 
Conditions that affect the degree of foaming during fermentation include 
gas introduction (i.e., aeration), medium composition and viscosity, cell 
growth, metabolite formation, surface-active substance formation, and 
indirectly, vessel geometry. Several chemicals compound (silicon based, 
polyesters and natural oils) have been developed for foaming control. 
Stirring disperses antifoams and foam is destroyed by bubble 
coalescence. It must be taken into account that is important to remove 
antifoam impurities from the final product through the downstream 
process [26].  
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1.2.3. From laboratory to manufacturing: fermentation scale up  
Before manufacturing of a product can be implemented in a large-scale 
facility, the process is usually established at a bench scale within a 
bioreactor of a few liters of volume. Fermentation scale-up is aimed at 
the manufacture of larger product quantities, if at all possible, with a 
simultaneous increase or at least consistency of specific yields and 
product quality. To increase product yields and to ensure consistent 
product quality, key issues of industrial fermentations, process 
optimization and scale-up are aimed at maintaining optimum and 
homogenous reaction conditions minimizing microbial stress exposure 
and enhancing metabolic accuracy [28]. 
Aerated and anaerobic fermentations at the laboratory scale are 
typically carried out in shaken (not stirred) flasks in an incubator-shaker. 
Air is used to both heat and cool the shake flasks that are agitated by an 
orbital motion of the shaker table. The flasks, nutrient medium, and caps 
are sterilized at 121 °C for 30 min in an autoclave. Steam is needed to 
obtain effective killing of microorganisms and spores that might be found 
in the flask or nutrient solution [27]. 
Shake flask studies are used early in the development of an industrial 
fermentation since multiple nutrient compositions and different cultures 
can be evaluated in parallel studies, in the same incubator. The pH in a 
shake flask is controlled using buffer, while other nutritional factors are 
controlled by the makeup of the broth. The circulation of air in the 
incubator also serves to remove heat of fermentation. The oxygen 
requirements for aerobic microorganisms are met by the swirling action 
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of the shake flask, accompanied by diffusion of air through the porous, 
sterile, cotton plug that is fitted on top of the flask. 
Controlled laboratory fermentations at a larger scale are typically carried 
out in sealed glass vessels. Volumes of these vessels range from 1 to 
100 L, with the working volume (broth) typically being about 70% of the 
fermenter volume. Such a fermenter contains sealed ports for pH and 
pO2 probes, as well as ports for addition of acid or base for pH control. 
Aeration of the fermentation broth is carried out by bubbling compressed 
air that has been sterile-filtered through a 0.2-μm filter, into the bottom of 
the vessel. Ports enable samples to be taken for intermittent analysis by 
chromatography, mass spectroscopy, or other methods during the 
development phase for process characterization. These data are then 
used to generate graphs of the fermentation time-course. Heating and 
cooling of the fermenter is achieved by passing thermostating water 
through the jacket.  
Industrial-scale fermentation for manufacture of high-value products is 
carried out in large (from 1 to 120 m3), 316 stainless-steel vessels. The 
principle on which this equipment is based is similar to that of the 
laboratory-scale fermenter, although numerous and complex mixing, 
aeration, and other scale up issues must be addressed [27].  
For aerobic fermentations oxygen is an important nutrient that is used by 
microorganisms for growth, maintenance and metabolite production. Its 
scarcity can affect the process performance. The changed geometric 
and physical conditions in larger scales, however, can lead to a less 
favorable mixing behavior and to impaired physiological reaction 
conditions that, in turn, may lead to a decreased process constancy and 
reproducibility, to reduced specific yields and to an increase in unwanted 
side products and thus ultimately to a diminished batch-to-batch 
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consistency and product quality. These are key issues in industrial 
production processes [29]. The gas–liquid mass transfer in a bioprocess 
is strongly influenced by the hydrodynamic conditions in the bioreactors. 
These conditions are known to be a function of energy dissipation that 
depends on the operational conditions, the physicochemical properties 
of the culture, the geometrical parameters of the bioreactor and also on 
the presence of oxygen-consuming cells [30]. 
As such, one of the most challenging parts of fermentation scaling-up is 
represented by mixing studies and several experimental and 
computational methods have been developed [31]. 
An essential prerequisite for high product yields in larger scales, in 
which cultures pass a higher number of generations due to larger culture 
broth volumes, is the stable propagation of plasmids to daughter cells. 
Plasmid stability is influenced by the plasmid size and nucleotide 
sequence as well as by process parameters like temperature, growth 
rates, and substrate concentrations [32,33]. Plasmid stability and 
plasmid numbers are thus negatively influenced, more difficult to control, 
and less easy to be maintained in larger scales. A concept to render 
plasmid stability and expression rates more independent from such 
physiological influences is the application of runaway plasmids. Their 
replication can be induced separately from growth in the desired 
fermentation phase [34], enabling copy numbers of up to 1000 in the 
expression phase. A prioritized goal of process optimization and scale-
up thus consists of an appropriate process design that improves the 
physiological conditions and the metabolic accuracy by minimizing 
microbial stress exposure. 
The optimization of the fermentation conditions for the chosen strains 
involves evaluation of a large number of variables: these include 
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medium composition, nutrient feeding regimes and physical variables 
such as temperature, pH and dissolved oxygen levels. In facilitating 
parallel operation, small scale bioreactors enable increases in the rate at 
which the necessary experiments are performed thus reducing 
fermentation development times and costs 
 
1.2.4. Aerobic fermenter designs in submerged fermentations 
Fermenters are quite complicated in design by virtue of the fact that they 
must allow a precise control and meticulous observation of the 
numerous facets of microbial growth and product biosynthesis. As larger 
is the size of the tank the more difficult is keeping the process under 
control. Independently from their configuration, industrial fermenter for 
sterile operations are designed as pressure vessels, capable of being 
sterilized in-situ with saturated steam.  
The most common fermenter systems used for submerged 
fermentations can be divided into: stirred tank, bubble column and air-lift 
fermenters (Fig. 5). 
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Fig. 5: Schematic representation of stirred tank (a), bubble column (b) and air 
lift (c) fermenters. 
 
Bubble column reactors are cylindrical tank sparged at the bottom with 
the air, which provides agitation. They have excellent heat and mass 
transfer characteristics, meaning high heat and mass transfer 
coefficients. Little maintenance and low operating costs are required due 
to lack of moving parts and compactness.  
Several bioprocess studies have been carried out with bubble columns 
fermenters for the production of antibiotics [35]. 
Air-lift fermenters are characterized by fluid circulation in a defined cyclic 
pattern through channels built specifically for this purpose. Medium is 
pneumatically agitated by a stream of air or sometimes by other gases. 
In addition to agitation, the gas stream has the important function of 
facilitating exchange of material between the gas phase and the 
medium; oxygen is usually transferred to the liquid, and in some cases 
reaction products are removed through exchange with the gas phase. 
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The main difference between air-lift fermenters and bubble columns 
(which are also pneumatically agitated) lies in the type of fluid flow, 
which depends on the geometry of the system [36]. Cephalosporin C 
production has been investigated by using air-lift fermentations [37]. 
Stirred tank fermenters (figure 6) have a central shaft supporting the 
impellers (from 1 to 3 or 4), which determines the main degree of bulk 
mixing properties. There are several other design factors that affect 
mixing quality in a fermenter. In addition to impeller choice, their 
diameter (usually from 0,35 to 0,5 of the vessel ratio) and spacing 
(usually 1/1,5 impeller diameter) must be taken into account. Baffles 
also influence mixing: they are placed in vessels to minimize fluid 
swirling and vortex formation. The usual approach is to use four baffles 
on 90 °C centers, each baffle having a width equal to 0.1 of the vessel 
diameter. 
Fermenters are provided, at the level of liquid, of ports for temperature, 
pH and DOT sensors for continuous monitoring. A steam-sterilizable 
sampling valve takes place at that level. Lines for the addition of alkali 
and acid (for pH control), antifoam agents, substrate and inoculum are 
located above the liquid level I the bioreactor vessel. Filter sterilized 
gasses are supplied through a submerged sparger or from the top in 
case of top aeration fermentations. Harvest valve and line is located at 
the lowest point o the fermenter.  High-speed foam breaker may be 
installed at the top of the vessel. Gasses are vented through an exhaust 
gas line that can also be provided by a cooling system to condense and 
return water in the gas to the fermenter. The top of the fermenter is 
removable and provided by a rupture disk in case of pressure build-up. 
A jacket cover the vessel for process thermostating [38].  
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Sterilization is carried out in place, and special designs are needed to 
minimize the risk of holdover of small amounts of liquid that could serve 
as reservoirs of microbial contamination from one batch to the next. 
Polished surfaces ad piping orbital welds minimize the occurrence of 
small pores or pockets in the metal that might retain microbial spores 
ensuring system clean-ability. Layout of the piping must ensure that 
there are no low spots where liquid could pool and be a source of 
contamination.  
 
 
Fig. 6: Diagram of an instrumented fermenter for aerated fermentation of 
products generated under sterile conditions in a closed, agitated vessel. This 
type of fermenter may range in volume from 20 to 200,000 L. Metal 
construction usually consists of polished type 316 stainless steel [39].  
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Various types of impellers, that direct the flow axially (parallel to the 
shaft) or radially (outwards from the shaft) may be used  (Fig. 7). Radial 
flow impellers tend to deliver the high power required to enhance micro-
mixing and mass transfer but do not promote top-to-bottom mixing; 
therefore, they are not the best choice for promoting homogeneity. 
Multiple radial flow impellers often are used in an attempt to compensate 
for poor bulk mixing. This can work fairly well for low-viscosity 
Newtonian broths, but it is a very poor solution when the broth is very 
viscous and highly non-Newtonian. Pure axial flow impellers do not 
deliver much power but do tend to promote good top-to-bottom mixing 
and hence contribute significantly to bulk homogeneity. Some mixed 
flow types appear to provide a good balance between bulk mixing and 
mass transfer requirements, particularly for non-Newtonian broths [41]. 
Those configurations with Rushton as the lower impellers and a hydrofoil 
on top appear to work well for Newtonian and non-Newtonian broths. 
This configuration also provides also a mechanical effect for foaming 
control [40]. 
 
54 
 
Sergio Pirato – PhD Thesis 
 
 
Fig. 7: Impellers for stirred-tank fermenters. (A) Rushton disc turbine (radial), 
(B) Marie propeller (axial), (C) Lightnin hydrofoil (axial), (D) Prochem hydrofoil 
(axial), (E) Interning (axial), (F) Chemineer hydrofoil (axial)   
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1.3. Fermentation media and raw materials  
Media preparation can be considered as the backbone of the entire 
‘bioprocess operation’. It must be carried out with utmost care and 
precaution. Importantly, the improper and inadequate media design may 
ultimately give rise to both impaired efficiency of growth as well as 
concomitant significantly poor product formation. Optimization of 
fermentation process is a continuous and constant activity that plays a 
key role in industrial fermentation production with the aim of positively 
increasing the impact of products on companies’ economy. This key 
point occurs through the study of new methods in order to: increase the 
yield of products; decrease production costs; improve or simplify 
production processes. 
When developing an industrial fermentation, designing a fermentation 
medium is of critical importance because medium composition can 
significantly affect product concentration, yield and volumetric 
productivity. In addition, it must be taken into account that raw materials 
in fermentation can range from 15 to 60 % of total costs and that 
medium composition can also affect the ease and cost of downstream 
product separation. 
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Challenges at laboratory level Challenges at industrial scale 
Development time Availability of raw materials 
Costs and efforts Transport costs 
Foaming 
Batch to batch variability of complex 
media 
Precipitation reactions Medium costs and prices fluctuations 
Water quality Stability of suppliers 
Dispersion of solid components Bulk storage and handling 
Effect of component on analytical 
assays 
Effects of components on medium 
viscosity 
Effect of components on downstream 
processes 
Disposal costs 
Tab. 2: Constraints and challenges that may operate during the process of 
designing an industrial medium [42] 
 
There are many challenges associated with medium design. Designing 
the medium is a laborious, expensive and often time-consuming process 
involving many experiments. In industry, it often needs to be conducted 
frequently because new mutants and strains are continuously being 
introduced. Many constraints operate during the design process, and 
industrial scale must be kept in mind when designing the medium. Some 
of these constraints and challenges are summarized in Table 2  [42]. 
Culture medium design and optimization can be approached in two main 
ways. In “close” systems a fixed number of medium component are 
analyzed for optimization assuming the choice of the right components 
to start with. This is the simplest strategy but many different possible 
components that are not considered could be beneficial for microbial 
growth and yield improvement. An “open” system makes no assumption 
of which components are best for fermentation medium; several 
numbers of raw materials are analyzed for medium optimization. The 
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best way would be starting with an open-ended system, select the best 
components and then move to a close-ended system [43]. 
Several simple and complex methods have been developed to optimize 
fermentation media: 
- Component replacing method in an “open-ended” system that 
consists in replacing one component with a new one at the same 
degree. This method is useful for screening different carbon or 
nitrogen sources. 
- The biological mimicry strategy (“closed-ended”) is based on the 
concept that the cell will grow well in a medium that contains 
everything it needs in the right proportions. It is simply a mass 
balance strategy. The composition of the cell, the concentration of 
cell mass, cell growth yields, and the desired extracellular product 
concentrations are used to calculate how much of the various 
components should be in the medium [42].  
- The one factor at time strategy is a “close-ended” extremely 
simple because based on changing one variable (raw material but 
also a process parameter) at time, keeping the other constant. It 
is expensive and time consuming due to the large number of 
experiments needed to explore the several variables that 
characterize fermentation media. Because of its ease and 
convenience, this method has been one of the most popular for 
improving medium composition [44]. 
In order to change more than one factor at a time, experimental design 
approach is needed. Applications to medium improvement date from the 
1970s and many studies claim substantial improvements over media 
obtained using ‘one-at-time’. 
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To improve a medium using the experimental design approach requires 
both a design and an optimization technique. The design specifies the 
medium variants to test in the experiment, including the number of 
replicates and the arrangement of tests into homogeneous ‘blocks’. 
Then, using the experimental data, the optimization technique employs 
a mathematical model to predict an improved medium composition. Full 
factorial design covers all the possible combination among several 
variables (or factors) but is characterized by a large number of 
experiments.  This approach is widely used  to investigate the effect of 
medium components on fermentation performance of several bio-
products such as enzymes and antibiotics [45,46], but it is also used to 
investigate other factors such as strains, temperature or inoculum phase 
for the improvement of lipids [47], citric acid [48] as well as antibiotic 
[49] fermentations. Partial factorial design used when the number of 
runs required in a full factorial is impracticable. In medium improvement 
applications, these are usually two-level fractional factorial designs [50]. 
 
1.3.1. Nutrients and complex media All micro-organisms require 
water, sources of energy like carbon, nitrogen, mineral elements and 
possibly vitamins, plus oxygen if the process is aerobic. On a small 
scale it is relatively simple to devise a medium containing pure 
compounds, but the resulting medium, although supporting satisfactory 
growth may be unsuitable for use in a large scale process. 
The most common microorganisms employed in industrial processes are 
the chemo-heterotrophs. These employ organic compounds as principal 
source of carbon for energy (ATP) production by using oxygen as 
acceptor of electron. Nutritional factors coupled with essential and trace 
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elements are also required and combined in various ways to form 
cellular material and products. 
Fermentation nutrients are generally classified as: sources of carbon, 
nitrogen and sulfur, minerals and vitamins (Tab. 3)  
 
Source Raw Material 
Carbon & 
energy 
Molasses, Whey, Grains, Agricultural wastes and 
vegetable oils. 
Nitrogen 
Corn steep liquor, Soybean meal, Peptones, Yeast 
extracts, Ammonia and ammonium salts, Nitrates 
Vitamins 
Crude preparations from inorganic or plant and animal 
products 
Iron & trace salts 
(minerals) 
Crude preparation from inorganic 
Antifoam agents 
Higher alcohol, silicones, natural esters, lard and 
vegetables oils 
Tab. 3: Major components of growth media used in Industrial fermentations 
 
Carbohydrates and oils, usually the main components of fermentation 
media,  are excellent sources of carbon, oxygen, hydrogen, and 
metabolic energy. They are frequently present in the media in 
concentrations higher than any other nutrients and are generally used in 
the range of 0.2-25% [51]. The availability of the carbohydrate to the 
microorganism normally depends upon the complexity of the molecule. 
Sugar beet and sugarcane are the main sources for saccharose and 
saccharose-rich molasses. The most important starch sources are 
cereals (corn, wheat, rice), manioc, sweet potatoes and potatoes (Tab. 
4).  
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Plant Corn Wheat Potatoes Manioc 
Sweet 
potatoes 
Average starch 
content (%) 
60-70 55-70 12-20 20-40 19-25 
Tab. 4: Starch content of plants [55] 
 
The world production of starch is greater than 50 million tons per year 
(roughly 69% from corn, 10% from manioc, 9% from sweet potatoes, 6% 
from wheat, 6% from potatoes and less than 1% from other sources) 
[52]. The main producers are represented by  USA, EU, China and 
Japan. Corn or maize (Zea mays) is an annual grass. The starch is 
located in the grains and most commonly processed by wet milling. After 
steeping the grains, germ separation, milling and sieving, starch is 
separated from the protein gluten and from fibers. The starch slurry is 
then purified and dried. The remaining liquid from the steeping stage 
called corn steep liquor is also a fermentation feedstock applied as 
nitrogen or even carbon source. However, corn steep liquor composition 
may vary depending on the supplier. 
Maltose is produced by enzymatic degradation of starch liquefacts using 
β-amylase. A huge amount of different raw starch degrading enzymes, 
which are able of providing different degree of starch debranching, are 
present on the market [53]. Applying a debranching enzyme (e.g. 
pullulanase, isoamylase) to the α-amylase allows reaching maltose 
contents of 75–80%. Glucose is produced by enzymatic degradation of 
starch liquefacts using glucoamylase. Sometimes debranching enzymes 
are added for a more efficient hydrolysis. The glucose content of the 
resulting glucose syrup depends on the conditions adopted for the 
production. Using further concentration and purification methods, 99% 
pure glucose syrup can be produced. 
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Other two raw materials used as carbon source are inulin and 
lignocelluloses [54], whey and sulphite spent liquor [55].  In particular, 
the use of lignocelluloses’ biomass for fermentations is still under 
research and pilot phase in contrast to raw materials derived from sugar 
and starch plants that are used in industrial scale. 
The nature of the carbon source used as raw material for fermentations 
depends first on the particular fermentation process as well as the 
requirements and productivity of the microorganisms. Within the range 
of suitable raw materials that meet the technological, processing and 
quality demands of the bioprocess, the raw material price will be crucial. 
Prices (Tab. 5) for some carbohydrate sources are reported in below 
[56].  
 
Carbohydrate 
substrate 
Fermentable 
carbohydrate (%) 
Price ($/Kg) 
Saccharose 100 0,20-0,30 
Molasses 47-53 0,15-0,25 
Dextrose, monohydrate 91 0.30-0.60 
Glucose, syrup 70% 70 0,30-0,60 
Corn starch 85 0,25-0,60 
Shredded corn 70 0,10-0,45 
Lactose, edible 94 0,50-0,90 
Lactose, crude 48 0,15-0,20 
Dry whey 75 0,50-1,30 
Whey permeate 79 0,45-0,70 
Fructose 100 1,00 
Tab. 5: Average prices for carbon substrates 
 
Nitrogen is generally the next most important substance in the 
fermentation media. A few organisms can also use the nitrogen source 
as the energy source. Nitrogen and sulfur are part of the organic 
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compounds of the cell, principally in reduced form (aminoacid-sulfhydryl 
groups). Some microorganisms are not able to reduce  one or both of 
these anions and, therefore, need to be supplied with the elements in 
the reduced form: nitrogen as ammonia salts and sulfur as a sulfide or 
as an organic compound like cysteine, which contains a sulfhydryl 
group, Organic nutrients as amino acids and more complex protein 
degradation products as peptones may also supply nitrogen and sulfur 
in the reduced form. Several products are available on the market as 
source of nitrogen for microbial cultures. 
Corn steep liquor (CSL) is a spin-off of starch extraction from maize [57] 
that was firstly used in penicillin production [58]. CSL composition varies 
depending on the quality of the maize, which is a direct consequence of 
environmental factors (soil, humidity, temperature etc.), and from 
harvesting and processing conditions. This raw material offers a wide 
range of aminoacid, minerals and vitamins (especially B group [59]); 
while the residual sugars are often converted in lactic acids by 
contaminants [60]. Due to the low cost with respect to the other nitrogen 
sources, CSL is widely used in high volumes (up to 90 m3) industrial 
fermentation for the production of antibiotics [61]. 
Yeast Extract is manufactured from baker and brewer’s industry through 
the autolysis of Saccharomyces cerevisiae. Other strains are 
Kluyveromyces fragilis (fermented on whey) or Candida utilis (grown on 
high carbohydrate waste-products of the timber industry or on ethanol) 
[62].  
Yeast Extracts for fermentations is a standard salt-free raw material 
composed mainly by a protein content of 70-80 % (powder). Sodium and 
polysaccharide contents do not exceed 0.5 % and 5 % respectively. 
Oligosaccharide contents are less than 1 %. They consist of mannan 
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and glucan fractions. A moderate content of group B protein 
characterize also this raw material. Fat contents less than 0.5 % do not 
have significant effects on the fermentation of microorganisms, however 
temperature, pH type of substrate medium for the growth of the 
Saccharomyces and duration of autolysis are all variables that create 
the large variety of yeast extracts available.  
Peptones are expansive raw materials composed mainly by proteins that 
are produced by the hydrolysis of meat, casein, gelatin and keratin. 
Depending upon the source, a different aminoacid pattern can be 
obtained [63] 
Soy peptones are all enzymatic digests of soy flour. Soy flour, the 
principle substrate in a soy peptone, is rich in high-quality protein, 
carbohydrates, calcium and B vitamins. The enzymes used in the 
digestion of soy flour are typically from animal-free sources or from 
microorganisms that have been grown in animal-free media. 
With the continuing emergence of new confirmed cases of Bovine 
Spongiform Encephalopathy (BSE), a prime directive for the 
development of new fermentation products, has been to either source 
raw materials from a country free from BSEs or reformulate the media 
using animal-free components. The use of serum-free media and the 
related genera of animal-free and protein-free media have increased 
significantly over the past 15 years. This is particularly true in industrial 
applications, in which the use of serum presents a safety hazard and a 
source of unwanted contamination in the production of 
biopharmaceuticals [64]. To reduce the risk of known contaminants such 
as BSE and yet unknown agents, biopharmaceutical health authorities 
are pushing cell culture manufacturers to take increased levels of care in 
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choosing raw materials for their products, especially for inject-able 
products such as vaccines [65].   
Trace elements for fermentation include iron (Fe2+ and Fe3+), zinc 
(Zn2), manganese (Mn2), molybdenum (Mo2), cobalt (Co2), copper 
(Cu2), and calcium (Ca2). They serve in coenzyme functions to catalyze 
many reactions, vitamin synthesis, and cell wall transport. They are 
required at low levels, can sometimes even be supplied from quantities 
occurring in water and may contribute to both primary or secondary 
metabolite production. Manganese can influence enzyme production. 
Iron and zinc have been found to influence antibiotic production [66]. It 
was demonstrated that diphtheria toxin produced by Corynebacterium 
diphtheriae was drastically reduced by high iron content in fermentation 
medium due to its induction of diphtheria toxin repressor expression 
[67]. 
Like trace elements, vitamins are required in a small amount and are 
suitable for many metabolic reactions.  The vitamins most frequently 
required are thiamin and biotin. In a greatest amounts are usually niacin, 
pantothenate, riboflavin, and some (folic derivatives, biotin, vitamin B) 
are required in smaller amounts. In industrial fermentations, the correct 
vitamin balance can be achieved by the proper blending of complex 
materials and, if required, through the addition of pure vitamins [68]. 
Group B vitamins have been demonstrated to increase lactic acid yield 
in Lactobacillus paracasei fermentation [69]. 
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1.3.2. Raw materials control strategies Control of raw materials is 
essential for maintaining safety and quality of products. In most of the 
cases the Certificate of Analysis (CoA) provided by manufacturers are 
not enough to ensure the desired characteristics: the material ordered 
might include additives, preservatives, degradation products, or 
contaminants. As such, regulatory agencies are moving toward detailed 
requirements for raw materials used in biopharmaceuticals and 
companies are more often obliged to perform additional test. 
International Conference on Harmonization (ICH) Q7 guideline deeply 
discuss the need to control materials with appropriate specifications.  
From a process point of view, raw material control is also essential to 
ensure lot-to-lot consistency because their variation can directly affect 
both product quality and process. Manufacturers must understand the 
Critical Material Attributes (CMAs) of their raw materials and which of 
those affect variability. 
Both blackstrap and beet molasses are widely used in the fermentation 
industry. Variability in molasses quality was demonstrated to strongly 
affect alcohol production by Saccaromices cerevisiae fermentation [70], 
which is related with environmental and harvesting processes that can 
impact nutritional properties and/or impurities content [71]. Yeast extract 
and soy hydrolysate have been demonstrated to affect fermentation 
protein products and chemometric approach were used to understand 
raw material variability and cell culture performances [72,73]. 
From a quality by design approach, raw materials can be therefore 
divided into critical, key and non-key in order to focus and then identify 
CMAs. 
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Critical raw materials are known to significantly affect product quality 
and these raw materials are, therefore, thoroughly characterized and 
their mechanisms of process interactions well understood in order to 
make appropriate risk assessment. Key raw materials do not 
significantly affect product quality but do impact process consistency. 
Non-key raw materials include the remaining (and majority of) raw 
materials [74]. 
During the last 10-15 years, some analytical method models have been 
developed as supported by statistic tools such multivariate analysis in 
order to reduce or foresees raw materials variability. Currently, tests with 
fingerprint techniques, Nuclear Magnetic Resonance (NMR). Imaging 
(MRI) and Raman, Near Infrared (NIR), and Fourier-Transform Infrared 
(FTIR) spectroscopy are used to assure quality and performances of raw 
materials. Once CMAs are understood there is the need to identify which 
tests are relevant for testing specific quality attributes (QAs) of those raw 
materials.       
 
1.3.3. Defined media Chemically defined media are widely used in 
some commercial fermentation, particularly in biological products. 
Although they exhibit favorable characteristics that are not observed with 
traditional complex media, they are not widely used in large-scale 
fermentation, when complex media are preferred since less expansive.  
Chemically defined media consist of only chemically defined ingredients 
added to purified water for the cultivation of microorganisms, 
mammalian or insect cells. Defined media include no complex 
ingredients such as proteins, hydrolysates, animal-derived ingredients, 
or constituents of unknown composition. Up to date, applications of 
defined media range from laboratory scale metabolic studies to 
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production scale fermentation or cell culture. Metabolic studies have 
been recently carried out on Lactococci, Enterococci, and Streptococci 
growth by experimental leave-one-out technique in order to determine 
the necessity of each of the 57 chemical components used in medium 
development [75]. 
Defined media offer several advantages in terms of lot-to-lot variability: 
they can be easily reproduced, have low foaming tendencies and allow 
easy product recovery and purification. 
Despite the advantages, chemically defined media are rarely used in 
industrial fermentations because complex media usually allow higher 
yields at lower cost [76]. Complex ingredients that are inexpensive by-
products of food and agriculture industries will provide a majority of 
nutrients needed for bacterial and yeast fermentation 
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Aim of the Work 
 
The research carried out within the second part of this Doctorate Thesis 
project is focused on raw materials studies for fermentation bioprocess 
improvements.  
A high-yield Streptomyces ambofaciens strain has been involved in this 
study of medium and fermentation process improvement for the 
production of the macrolide antibiotic spiramycin. Several studies on raw 
materials used in the fermentation process have been carried out for 
yield improvement experiments. Activities were focused on starch 
studies; even if native starch is cheaper than the modified one 
(enzymatically or chemically digested), the use of modified starch was 
forced due to the impossibility of enzymatically digesting native starch 
directly into the industrial fermenter as in the case of laboratory 
fermentation. Modified starch revealed an improved medium mixing, with 
an higher dissolved oxygen concentration; this effect was due to the 
lower viscosity of the medium, which provided better fermentation 
conditions. 
Further studies were undertaken in order to investigate the possibility of 
modifying trace elements and iron solutions addition, with the aim of 
simplify the process eliminating contamination risks. The addition of 
these solutions can occur directly into the medium before sterilization 
instead of 20 hours after the inoculum through manual sterile 
connection. The obtained results show how spiramycin yield and 
impurities content are not affected by this modification.  
Corn Oil batches from different suppliers were also studied to improve 
antibiotic yield: spiramycin productivity, in presence of the new Corn Oil, 
showed a similar behavior with the standard during the beginning of 
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fermentation. On the contrary, at the end of fermentation productivity it 
was higher because oil was slowly used by the microorganism.  
The last part of the thesis is focused on a NIR (Near Infrared 
Spectroscopy) approach for the development of a prediction model of 
yeast extract performances in Corynebacterium diphtheriae 
fermentation. Yeast extract was chosen as it strictly correlates with 
Diphtheriae toxin yield. Several yeast extract batches were investigated 
in term of aminoacid composition and no evident differences were found 
between high and low performing samples. Preliminary studies, 
performed with Spectrum Quant+® software for quantitative and 
qualitative analysis, seem to allow defining a prediction model for 
outcome yield depending on yeast extract batches used in Diphtheriae 
fermentation. Even though the promising results, the NIR based method 
for yeast extract screening and high yield batches identification needs to 
be further investigated. 
 
 
 
List of Abbreviations 
 
 AVI (Absolute Virtual Instrument) 
 CRM197 (Cross-Reactive Material) 
 DO (Dissolved Oxygen) 
 GC/MS (Gas Chromatography-Mass Spectrometry) 
 HPLC (High Performance Liquid Chromatography) 
 ICP-OES (Inductively coupled plasma-optical emission spectrometry) 
 MLR (Multiple Linear Regression) 
 MFCS (Multi Fermenter Control System) 
 NIR  (Near-infrared spectroscopy) 
 NIST (National Institute of Standards & Technology) 
 PBS (Phosphate Buffered Saline) 
 PC  (Principal Components) 
 PCA (Principal Component Analysis) 
 PCR (Principal Component Regression) 
 PCV (Packed Cell Volume) 
 rpm (rotation per minute) 
 SE-HPLC (Size Exclusion- High Performance Liquid Chromatography) 
 SIMCA (Soft independent modeling of class analogies) 
 U-HPLC/MS (Ultra-High Performance Liquid Chromatography-Mass 
Spectrometry) 
 VVM (Volume x Volume x Minute) 
 WCB (Working Cell Bank) 
 YE (Yeast extract) 
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2. Raw Material studies for antibiotic yield 
improvement 
2.1 Abstract 
A high-yield Streptomyces ambofaciens strain has been involved in this 
study of medium and fermentation process improvement for the 
production of the macrolide antibiotic spiramycin. In order to increase 
antibiotic yield and simplify the fermentation, several studies on raw 
materials used in the fermentation process have been done. 
Fermentations were carried out at 20 litres scale bioreactors and 
fermentation parameters were monitored through MFCS (Multi 
Fermenter Control System) software, raw materials consumption and 
spiramycin yield were monitored off-line by HPLC. 
Starch studies revealed that, even if native starch is cheaper than the 
modified one, the use of modified starch was forced due to an improved 
medium mixing, with higher dissolved oxygen concentration (direct 
consequence of the decreased medium viscosity) providing better 
fermentation conditions. 
Trace elements and iron solution addition in the fermentation medium 
occurs usually after 20 hours from the beginning of the process through 
a 0,22-m sterilization. Further studies investigated the possibility of 
adding these solutions directly into the medium before heat sterilization 
with the aim of simplify the process and eliminate contamination risks. 
The obtained results show how spiramycin yield is not affected by this 
change: the addition of these solutions can occur directly into the 
medium before sterilization instead of after 20 hours, through manual 
sterile connection. 
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As part of the raw materials employed in spiramycin fermentation, corn 
oil was figured out to have an impact of antibiotic yield. Corn oil batches 
from different suppliers were investigated and antibiotic yield increased 
of about 10 % without affecting the purity degree. 
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2.2 Introduction 
Industrial production of antibiotics must be considered at different levels: 
biological development (Screening and selection, mutation and strain 
maintenance); development and optimization of the fermentative 
process and transfer for large-scale production [1]. 
Optimization of fermentation processes is a continuous and constant 
activity, which plays a key role with the aim of positively increasing the 
impact of products on companies’ economy. This key point occurs 
through the study of new methods in order to: increase the yield of 
products; decrease production costs; improve or simplify production 
processes. 
When developing an industrial fermentation, designing a fermentation 
medium is of critical importance because medium composition can 
significantly affect product concentration, yield and volumetric 
productivity. There are many challenges associated with medium 
design. Designing the medium is a laborious, expensive, open-ended, 
often time-consuming process involving many experiments. In industry, 
it often needs to be conducted frequently because new mutants and 
strains are continuously being introduced. Many constraints operate 
during the design process, and industrial scale must be kept in mind 
when designing the medium [2,3]. 
Antibiotic production is influenced by the nitrogen [4-7], carbons [8,9] 
and phosphate sources [10,11] used in the fermentation medium. 
Additional feeds of medium ingredients, precursors, or complete medium 
using fed-batch culture are often found to extend biosynthesis and result 
in greater productivity of the desired metabolite.  
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Macrolide includes a group of broad-spectrum antibiotics containing a 
lactone ring. The main macrolide antibiotics are erythromycin, 
magnamycin (carbomycin), oleandomycin, angolamycin, methylmycin, 
lancamycin and spiramycin. All macrolides carry out their function by 
blocking the ribosomal peptide exit tunnel, thus preventing peptide chain 
elongation [12]. Spiramycin has been isolated from a previously 
undescribed species which was named Streptomyces ambofaciens from 
soils in northern France, Rey et al. [13] noted that spiramycin is a 
mixture of compounds which are similar in their elementary composition 
as well as in their physical, chemical and bacterial properties. 
The spiramycin molecule consists of a polyketide lactone ring 
(platenolide) synthesized by a type I polyketide synthase, to which three 
deoxyhexoses (mycaminose, forosamine, and mycarose) are attached 
successively in this order (Fig. 1). These sugars are essential to the 
antibacterial activity of spiramycin [14]. The antibacterial spectrum 
includes the Gram-positive organisms and Neisseria, but it also shows 
weak activity against some Gram-negative bacteria. 
 
 
Fig. 1. Chemical structure of Spiramycin: type I shows greater antimicrobial 
activity. 
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Spiramycin medium has been studied and improved during the past 
years. Ammonium formation as part of some aminoacid catabolism 
negatively influence spiramycin productivity [15,16]. The role of 
aminoacid and micronutrients was investigated demonstrating the 
positive effect of tryptophan, Manganese, Cobalt, Zinc and Molybdenum 
on antibiotic yield [17]. Dextrin removal from the fermentation medium 
increased the assimilation of some group of aminoacid then others 
contained in yeast extract, reflecting variation in spiramycin yield [18].  
Soybean oil and propylic alcohol addition to fermentation medium 
improved productivity in a 60 m3 scale fermentation [19]. Most recently 
has been demonstrated that, providing the methylation reagent choline 
chloride during spiramycin fermentation and improving the 
supplementing conditions by one-factor-design approach, spiramycin 
titer was increased about 15% and the primary impurities were 
decreased [20]. 
 
2.3 Materials and methods 
2.3.1 Bacterial strain, media and culture conditions. 1 ml of 
Streptomyces ambofaciens Working Cell Bank (WCB) maintained in 20 
% glycerol at – 80 °C, was thawed and diluted 1:10 with PBS. 1ml 
inoculated into a 300 ml flask containing 40 ml of vegetative medium 
(Spira_V) and incubated at 30°C for a maximum of 29 hours on rotative 
shaker at 250 rpm. 
Pre-culture inoculum occurred when vegetative fermentation reaches 
the following conditions: 
 pH value is decreasing as consequence of medium acidification  
 Packed Cell Volume (PCV) > 10% 
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 Glucose concentration < 2 g/l 
One flask of vegetative medium (40 ml) was used to inoculate the pre-
culture medium (Spira_P) in 20 liters BIOSTAT CF3000 bioreactor 
(Sartorius) containing 13 liters of working volume. Pre-culture 
fermentation was carried out at 30 °C, 500 rpm, air flow set at 0,3 VVM 
and overpressure at 500 mbar. After almost 24 hours, pO2 concentration 
falls down and is kept at 20%, by automatically increasing the impeller 
speed, until the second peak of CO2 production occurs (Fig. 2).  
 
 
Fig 2. Preculture growth. Transfer into the fermentative medium occurs when 
indicated by the red line. Details of pH and PCV are listed into the red box.   
 
650 ml of the preculture are used to inoculate a 20 L bioreactor 
containing 13 L. of fermentative medium (Spira_F). Inoculation 
percentage is 5%. During this step the temperature was kept at 30 °C 
for the firsts 30 hours to promote microbial growth and then shifted at 25 
°C until the end of fermentation to promote secondary metabolism for 
antibiotic production. Stirring speed was 750 rpm; airflow was set at 0,5 
VVM and pressure at 0,4 bar, while pH and pO2 were not controlled. 
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MFCS 2.1 software was used to monitor online fermentation 
parameters. Trace elements composed by CuSO4, ZnSO4, MnSO4, 
NaMoO4, CoCl2, KI, Al2(SO4)3, H3BO3 and NiSO4 and iron solutions were 
added after 20 hours of fermentation in the first study (through manual 
sterile connection) and directly into the medium before sterilization in the 
following studies. All the media were sterilized at 121 °C for 30 minutes 
and pH adjusted at 7,0  0,2 a using 30% sodium hydroxide solution. 
Modified starch was employed in all the fermentation, with the exception 
of those were performance differences between native and modified 
starch were assessed. 
2.3.2 Native starch digestion. In fermentations carried out with native 
starch fermentation medium was digested with the BAN-240 amylase 
(Novozymes). The enzyme solution stored at 2-8 °C was dilutes 1:30 
with distilled water and 3 ml were added to the medium. Digestion was 
carried out at 60 °C for 1 hour and after sterilization of the medium was 
performed. 
 
2.3.3 On-line measurements. MFCS (Multi Fermenter Control System) 
2.1 software has been employed to monitor online fermentation 
parameters: fermenters were provided with pH probe, pO2 probe, 
temperature, foam and overpressure sensors (Mettler-Toledo). GMUX 
(B-Braun) CO2/O2 gas analyzer was connected to the exhaust line to 
record gasses production. 
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2.3.4 Bioreactor configuration. In order to ensure an efficient mixing 
performance, the shaft has been provided of three Rushton impellers 
with 8,5 cm diameter and set at the distances reported below (Fig. 3). 
 
 
Fig 3. Configuration of the impeller geometry used in this fermentation. The 
distances listed must be considered from the end of the shaft. 
 
2.3.5 Off-line measurements. Medium samples were taken each 24 h 
in order to monitor the different parameters involved in strain growth and 
spiramycin production and purity. 
Microbial growth was monitored by measuring the Packed Cell Volume 
by using a T-CL 30 centrifuge (Thermo): 4000 rpm for 10 minutes. 
Glucose concentration was monitored to keep under control starch 
consumption: 5 grams of medium were chemically digested at 100 °C 
for 1 hour in presence of 5 ml of HCl 5N (Fluka). Then, 5 ml of NaOH 5N 
and 10 ml were added and sample was centrifuged at 4000 rpm for 10 
minutes. Supernatant was assayed for glucose measurement by using 
YSI 2300 STAT Plus™ Glucose-Lactate Analyzer. Spiramycin 
production was assessed from 92 hours until the end of fermentation: 
medium was clarified on paper filter and diluted 1:10 with distilled water 
and then with a buffer H2O:Acetonitrile (7:3). Dilution was adapted 
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depending on fermentation time and spiramycin concentration. 
Spiramycin was assayed by HPLC (Agilent 1100 System, Spectralab 
Scientific Inc.). Also Oil consumption was also monitored each 24 hours 
by HPLC using crude raw material as standard. 
 
2.4 Results and discussion 
2.4.1 Preculture growth. Typical trend of  Streptomyces ambofaciens 
preculture growth is reported in figure 2 (Fig. 2). Fermentative medium 
was inoculated after about 26 hours when exponential growth phase 
was reached, which was monitored from CO2 relative concentration in 
the exhaust gas line. Inoculum has been performed when the second 
peak of CO2 (blue line) occurred. 
 
2.4.2. Native vs modified starch. As starting investigation the 
difference of fermentation run with native or modified starch were 
evaluated: fermentations where carried out by adding trace elements 
after 20 h from the inoculum. Medium viscosity is one of the critical 
parameter that influence dissolved oxygen (DO) concentration: as long 
as viscosity increase more power is required to keep the DO to the 
desired setpoint.  Compared to modified starch, the native one has 
much longer polymer chains. Using native starch in fermentation 
medium increases its viscosity that, at 750 rotation per minute (rpm), 
gives a lower oxygen concentration into the culture broth. Antibiotic yield 
is negatively affected by the decreased DO during the whole 
fermentation (Fig. 4): spiramycin concentration at the end of the process 
was 4 fold less with native starch when compared with fermentation 
carried out with the modified (digested in advance). 
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Fig 4. Comparison of pO2 (solid lines) behaviors and spiramycin production 
(dashed lines) between fermentations carried out with modified (blue) and 
native (red) starch at 750 rpm. 
 
In a second experiment, stirring speed was increased to 900 rpm and 
spiramycin yield increased by almost 0,5 g/L. The final yield was, 
anyway, lower than in the fermentation carried out with modified starch 
(Fig. 5). Further investigations were not carried out because these 
conditions are not reproducible at industrial level. Modified starch was 
also quickly consumed rather than native one, reflecting an higher 
microbial growth as demonstrated by the PCV comparison (Fig. 6).  
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Fig 5. Yield comparison between fermentation carried out with modified starch 
at 750 rpm (blue line) and native starch at 900 rpm (red line). 
 
 
Fig 6. Starch consumption (solid lines) and PCV comparison (dashed lines) 
between fermentations carried out with native (blue) and modified starch (red).   
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2.4.3. Standard fermentation. The following figure (Fig. 7) shows a 
typical trend of the fermentation key parameters in spiramycin 
fermentation. Based on previous results (section 2.4.1), standard 
fermentation was chosen with modified starch (750 rpm) and trace 
elements added after 20 h from the inoculum: 
 CO2 trend (light green) is in correlation with microorganism 
metabolism, that switches from sugar to oil metabolism after 
around 65 hours, and indicate the beginning of spiramycin 
production. 
 pO2 trend (red) shows how at 13 L bioreactor level there are no 
problem of oxygen crisis, confirming appropriate mixing 
conditions. 
 Initial pH (light blue) decrease must be compensated with a rapid 
increase to value around 6,5 within 90 hours. Spiramycin 
productivity seems to be in a strict correlation with pH trend.     
 Air flow (blue) was kept at 0,5 VVM during all the process, 
lowering the flow as the working volume decreased due to 
evaporation. At laboratory scale fermentation media evaporation 
must be taken into account while, at industrial scale, culture level 
reduction is negligible due to the high volumes (up to 90 m3). 
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Fig 7. Typical trend of online measurements of standard fermentation carried 
out with modified starch. Trace elements and iron solutions added after 20 
hours of fermentation.   
 
Through off-line measurements (Fig. 8) of oil and starch consumption as 
well as spiramycin production the overall fermentation metabolism was 
monitored: 
 Massive oil consumption starts more or less at 90 hours. 
 Starch concentration decreases rapidly within 100 hours but 
does not reach the complete depletion, remaining at a 
concentration of about 2 g/L.  
 Spiramycin massive production coincides with the end of starch 
metabolism as well as with the beginning of massive oil 
consumption. As oil concentration decreases Spiramycin 
production tends to stop. This is the evidence of how secondary 
metabolism and, thus, spiramycin production are dependent 
from corn oil.  
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Fig 8. Off-line measurements of standard fermentation carried out with 
modified starch. Trace elements and iron solutions added after 20 hours of 
fermentation. The second Y axes reflects spiramycin value (yellow).   
 
 
2.4.4. Trace elements and iron solution addition study. In order to 
simplify the fermentation process and minimize contamination risks 
related with solutions addition during fermentation (through manual 
sterile connection), the addition of trace elements and iron solutions 
directly into the medium before sterilization was investigated. Two 
fermentation were run and, in both of them, the trend of the most 
important key parameters was not impacted (Fig. 9). The overall 
fermentation profile is comparable to the standard thus, meaning that 
the presence of iron and trace elements during the first 20 hours is 
suitable for the process.   
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Fig 9. Online measurement of fermentation carried out with iron and trace 
elements solution added directly into the medium during formulation.   
 
Spiramycin productivity is not affected by solutions addition before 
sterilization. The antibiotic yield was almost 5 g/L after 200 hours of 
fermentation in each trial (Fig. 10). Also starch consumption was not 
affected by this modification of standard protocol (data not shown). 
 
 
Fig 10. Spiramycin yield comparison between standard fermentation (blue) and 
fermentations carried out with iron and trace elements solution added directly 
during medium formulation (red and green)    
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There are no significant differences in terms of spiramycin and impurities 
ratio among the standard and the fermentations with iron and trace 
elements from the beginning; spiramycin relative concentration was 
always between 60 and 70 % as demonstrated by HPLC profiles (Fig. 
11). 
 
 
Fig 11. Comparison of the percentage ratio among spiramycin and impurities 
produced (right panel) and HPLC profiles (left panel) of medium samples at the 
end of fermentation: standard fermentation (A) and fermentations carried out 
with iron and trace elements solution added directly during medium formulation 
(B,C). 
 
2.4.5. Corn oil evaluation for yield improvement. As demonstrated by 
the oil consumption in the previous experiments, corn oil was figured out 
to be consumed during the stationary phase, when secondary 
metabolism occurs. It may indeed have a direct impact on antibiotic 
yield. As such, several batches from different suppliers were 
investigated in order to improve antibiotic yield. Three consecutive runs 
have been carried out with the new corn oil. Stirring (750 rmp), air flow 
(0,5 VVM), overpressure (0,4 bar) and temperature (30-25 °C) settings 
were kept constant among fermentations.  
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On-line parameters of fermentations carried out with new corn oil do not 
highlight substantial differences in terms of bacterial metabolic behavior. 
The same characteristic, previously described, of fermentation profile 
run in standard condition can be observed (Fig. 12). 
 
 
Fig 12. Fermentation profiles of the three runs carried out with new corn oil. A 
calibration issue of pH occurred in first run (top). Fermentation profile is 
comparable to the standard (Fig. 7)  
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The key metabolic indicators (pH and CO2) have been overlapped for a 
further evaluation (Fig. 13). Only minor differences, within the process 
variability, can be observed in the behavior of this metabolic indicators 
confirming the suitability of this new raw material for the process. 
 
 
Fig 13. CO2 (left) and pH (right) profiles comparison among standard 
fermentation (blue line) and fermentations run with different corn oil (other 
lines). 
 
Corn oil consumption was carefully monitored each 24 hours through 
HPLC (Fig. 14a) providing evidence on how new corn oil is consumed 
more slowly rather than the standard one.  
Starch consumption was monitored each 24 hours and it is comparable 
among all fermentations and stops when spiramycin production starts, at 
the end of the exponential growth phase, after about 100 hours from the 
inoculum as in standard fermentations (Fig. 14b).  
Packed Cell Volume (PCV) was assessed each 24 hours centrifuging 10 
ml of culture. No significant differences can be noticed in microbial 
growth (Fig. 14c); cell death starts after about 200 hours in all runs. 
Spiramycin production was assessed from the end of the exponential 
growth, each 24 hours until the end of fermentation, by HPLC analysis 
(Fig.14d). Spiramycin/impurities ratio was assessed  only in the final 
sample.   
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Fig 14. Oil (a) and starch (b) consumption, cell growth (c) and spiramycin 
productivity (d) comparison plots among standard fermentation (blue line) and 
fermentations run with different corn oil (other lines). 
 
Spiramycin productivity in presence of new Corn oil showed a similar 
behavior if compared with the standard. Differently, productivity behavior 
was different in the last part of the fermentation: 
- Standard fermentation productivity halted after about 200 hours 
- In modified medium fermentation productivity lasted additional 
25/50 hours leading to an increase of yield.   
This effect made by new corn oil correlates with the slower consumption 
of this material compared to the standard (Fig. 8).   
The relative percentage of spiramycin productivity is similar in all the 
performed trials as well as the  relative amount of known and unknown 
impurities. Spiramycin purity resulted over the specification limit of 50 % 
(Fig. 15) and reached almost 70 % degree in one of the three runs. 
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Fig 15. Relative percentage of total spiramycin productivity (orange) as well as 
known (green) and unknown (blue) impurities. 
 
2.5 Conclusions 
The impossibility of using native starch at industrial level was due to the 
low performing mixing abilities of the high working volume bioreactor 
commonly used for antibiotic production. Moreover digestion of  native 
starch at industrial level is not feasible because the medium is usually 
subjected to continuous sterilization (135 °C for 5 minutes) before being 
transferred into the industrial tank from the mixing tank. If the BAN 
amylase is added into the mixing tank it will be destroyed by the heat 
treatment. The investigation for the replacement of native starch with 
modified starch, in addition of helping to solve the mixing issue, led to an 
increased spiramycin yield by 0,3 and 0,5 g/L. 
Relating to obtained data, it is possible also to assert that performed 
tests provide strong evidence that the addition of trace element and iron 
solutions at the beginning of the fermentation does not affect strain 
potency in terms of spiramycin yield and impurities production, reducing 
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the contamination  risks associated with this step, that usually is done by 
aseptic connections. This could be also considered as further 
simplification of the process. 
Out of those analyzed parameters, spiramycin yield in presence of one 
of the new corn oil has been increased of about 11 % (0,5-0,6 g/L). Yield 
among the new fermentation is also characterized by low variability 
(Standard deviation = 0,25 g/L) with a mean of 5,95 g/L. No differences 
in term of purity degree was observed: in one of the carried out 
fermentations the product purity reached a 70 % level. About 5 % high 
rather than in previous fermentation experiments. 
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3. Near Infrared (NIR) Spectroscopy for yeast 
extract performance prediction in bacterial 
fermentation 
3.1 Abstract 
Yeast extract (YE) is commonly used as a key component in the 
complex media for industrial fermentations. However, the lot-to-lot 
variation of this raw material frequently requires extensive "use testing" 
of many lots to identify only the few that support desired fermentation 
performance. 
Yeast extract was figured out to strictly correlate with protein yield in 
Corynebacterium diphtheriae for inactive diphtheria toxin production. In 
this study, near-infrared spectra and bioassays of multiple YE lots were 
analyzed using chemometric approaches in order to address variability 
of raw materials as well as correlation between raw material properties 
and corresponding cell culture performance. Several yeast extract 
batches have been investigated in term of aminoacid composition and 
no evident differences were found between high and low performing 
yeast extract batches. NIR based method has been developed to use a 
predictive approach for yeast extract high  yield  batches identification.  
Principal component analysis by NIR spectra revealed  that  different YE 
lots contain enough physicochemical information about YE  to allow 
identification of lot-to-lot variability. Preliminary studies were performed 
with Spectrum Quant+® software for quantitative analysis and Assure 
ID® for qualitative analysis (Perkin Elmer). The performance of the 
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resulting model demonstrates the potential of NIR spectroscopy as a 
robust tool for the selection of  high performing YE batches. 
3.2 Introduction 
The production of pharmaceutical and biological compounds through 
microbial fermentation is a well-established practice. The rate of growth 
and the activity of metabolic processes may be strongly affected by the 
type and ratio of nutrients supplied  to the culture. Often, these nutrients 
are based on  raw materials that are complex mixtures of natural origin 
and subject to significant variation. Thus, product yields are adversely 
influenced when unknown variations of raw materials are encountered. 
Understanding variability in raw materials and their impacts on product 
quality is of critical importance in the biopharmaceutical manufacturing 
processes. For this purpose, several spectroscopic techniques have 
been studied for raw material characterization, providing fast and 
nondestructive ways to assess  their features [1].  
The most employed in pharmaceutical application are Ultra-High 
Performance Liquid Chromatography-Mass Spectrometry (U-HPLC/MS) 
for non-volatile polar components and Gas Chromatography-Mass 
Spectrometry (GC/MS) for volatile non-polar materials. Inductively 
Coupled Plasma-Optical Emission Spectrometry (ICP-OES) is also used 
to identify any traces of metal contamination present. NIR spectroscopy 
is also used for both raw materials control and in fermentation processes 
monitoring and control [2,3]. 
However, investigations of correlation between spectra of raw materials 
and cell culture performance,  in spite of their complexity, have been 
developed. 
Near-infrared (NIR) spectroscopy and imagining is a fast and non-
destructive technique that provides multi-constituent analysis of virtually 
any matrix. It covers the wavelength range adjacent to the mid infrared 
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and extends up to the visible region. Since multivariate NIR spectral 
data contain a huge number of correlated variables (co-linearity), there 
is a need for reduction of variables, i.e. to describe data variability by a 
few uncorrelated variables containing the relevant information for 
calibration modeling. The best known and most widely used variable-
reduction method is known as Principal Component Analysis (PCA). 
PCA is a mathematical procedure that resolves the spectral data into 
orthogonal components whose linear combinations approximate the 
original data. The new variables, called principal components (PC) or 
factors, correspond to the largest factor of the covariance matrix, thus, 
accounting for the largest possible variance in the data set [4]. 
Possible applications for this technology exist at all stages of the 
pharmaceutical manufacturing process; some examples are the 
characterization of raw materials, monitoring of product formation, and 
quality control in packaging. NIR spectroscopy has been applied in 
determining particle size, crystal forms, moisture, and active product 
concentration [5]. 
NIR imaging has been demonstrated to be as an effective tool for 
characterization of pharmaceutical powder blends for homogeneity 
studies [6]. NIR spectroscopy has been used, coupled with PCA 
analysis, to evaluate lot-to-lot variability of soy hydrolysate from different 
batches and vendors and its effect on cell culture growth and protein 
expression of two different cell lines [7]. 
CRM197 (Cross-Reactive Material) is an enzymatically inactive and 
nontoxic form of diphtheria toxin that contains a single amino acid 
substitution (G52E). Being naturally nontoxic, CRM197 is an ideal carrier 
protein for conjugation of  vaccines against encapsulated bacteria and is 
currently used to vaccinate children globally against Haemophilus 
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influenzae, pneumococcus, and meningococcus [8]. CRM197 is 
produced by Corynebacterium Diphtheriae  through fermentation under 
iron limiting conditions [9]. 
Yeast Extracts (YE) for fermentations is a standard salt-free raw material 
produced by the hydrolysis and spray-drying of baker’s or brewer’s 
yeast, is a powder consisting of protein, free amino nitrogen, vitamins, 
and minerals. YE is a key component in the complex media [10] 
however, the lot-to-lot variation frequently affects fermentation 
performance. It has been demonstrated how variation in yeast extract 
spectra can reflects fermentation yield fluctuations. In addition, a partial 
least-squares regression models has been used to predict cell mass 
yields in 15 L batch fermentations and specific product yields in 2 L 
shake flasks [11]. 
 
   109 
 
Sergio Pirato – PhD Thesis 
 
3.3 Materials and Methods 
3.3.1 Yeast Extracts. Yeast extract samples were obtained from 
different batches. Yeast extract samples (500 mg) were weighted in 5 
clear glasses (Wheaton of 4 mL or equivalent). Samples were frozen  at 
– 70 °C for one hour and then lyophilized at – 52 °C for 15 hours using a 
Lyovac® GT 2 (GEA) to remove water content. Samples were then 
stored at 25 °C. Fermentation yield data were based on retrospective 
analysis. 
 
3.3.2 Aminoacid composition analysis. The amino acid standard mix, 
obtained from the National Institute of Standards & Technology (NIST), 
consists of 17 amino acids (but not Trp or NorLeu) at concentrations 
ranging from 1.2 to 2.9 mM. NIST aminoacid solution was diluted with 
water up to concentration ranging from 120-290 μM. Trp and NorLeu 
were prepared separately at concentrations of 250 μM. Solutions were 
used for instrument calibration. Yeast extract samples at 50 g/L 
concentration were hydrolyzed with 6M HCl (Fluka) for 17 h in a 110 °C 
heating block. Samples and blanks were cooled to ambient temperature 
and transferred to 1.5 mL micro-centrifuge tubes and the HCl was 
evaporated to dryness using the SpeedVac Evaporator for 
approximately 2 h. Samples and blanks were reconstituted in 300 μL 
purified water and stored frozen until analyzed by AAA-Direct. 10 uL of 
samples were injected. Flow rate was set at 0,25 mL/min and 
temperature at 30°C. Eluents used were water, 250 mM NaOH and 1 M  
sodium acetate.  
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3.3.3 NIR analysis and software. YE samples were analyzed 2 hours 
and half after the lyophilization: each vial was analyzed twice and the 
vial turned of 180°, in order to increase the variability. Each session was 
repeated five times in different days. Spectra were acquired in the range 
4000-10000 cm -1 as log(1/R), with resolution of 16 cm -1 and 50 
scansions for each spectra. Yeast spectra were analyzed “untreated” 
and after the freeze drying cycle.   Spectrum_100N spectrofotometer 
(Perkin Elmer) was used for spectra acquisition.  
NIR spectra were processed with the Spectrum QUANT+® software for 
quantitative and qualitative data analysis. The software supported 
multiple linear regression, and partial least-squares regression and 
performed statistical analysis.  
In particular, Spectrum QUANT+ is a mulitcomponent analysis package 
based on Principal Component Regression (PCR). PCR is a regression 
analysis that uses principal component analysis when estimating 
regression coefficients. In PCR the principal components of the 
independent variables are used, instead of regressing the independent 
variables (the regressors) on the dependent variable directly. Principal 
components are calculated trough PCA. Soft Independent Modeling of 
Class Analogies (SIMCA) method was used for qualitative analysis. 
 
3.4 Results and discussion 
3.4.1. Lot-to-lot variability of yeast extract. Corynebacterium 
Diphtheriae is fermented in 1000 L bioreactor over-expressing CRM197 
protein. Product is subsequently clarified and diafiltered against PBS. 
Purification through two chromatographic columns and a concentration 
to the final volume complete the process. Final samples were analyzed 
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for protein content using the Lowry method and purity degree monitored 
by SE-HPLC is always above 90%. 
Historical data analysis revealed a strict correlation between the protein 
yield and the several yeast extract batches used in fermentation (Fig. 1). 
 
 
Fig. 1. Protein yield expressed in grams of total protein from different YE lots. 
Control chart of CRM197 yield by yeast extract batch 
 
A full complement of data was available for five different yeast extract 
lots, which are coded by the letters A, B, C, D, and E. Each of these lots 
were used as a nutrient in many replicate fermentations at large scale. 
These replicate fermentations define a range of yields for each lot, due 
to uncontrolled sources of variation in the fermentation processes. The 
average yield was taken as indicative of the performance of each yeast 
extract lot. 
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3.4.2. Aminoacid analysis. Since yeast extract is mainly an aminoacid 
source (nitrogen source) raw material, it has been investigated in terms 
of aminoacid composition in order to figure out possible differences 
between batches that could have explained this correlation with protein 
yield. No significant differences in terms of aminoacid composition were 
highlighted by the comparison among the different yeast extract batches 
used in manufacturing and therefore analyzed. The higher amount of 
Ala, Leu and Glu for YE batch B does not reflect differences in terms of 
yield when compared with lots A and C (Fig. 2), meaning that they are 
not directly involved in the observed lot-to-lot variability. 
During fermentation process, samples were taken for aminoacid 
consumption analysis and no significant differences were noticed in 
aminoacid consumption during fermentation among the analyzed 
batches (data not shown).   
 
 
Fig. 2. Amino acid composition comparison between low and high yield yeast 
extract batches 
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3.4.3. NIR analysis and prediction model development. Yeast extract 
batches A (low performing) and D (high performing) were analyzed 
using NIR Spectroscopy. YE drying conditions were optimized to reduce 
the effect of difference in water content. NIR Spectra were collected in 
reflectance mode and 15 replicates made of each measurement. 
Spectra are statistically analyzed after a Multiple Scatter correction and 
AVI (Absolute Virtual Instrument) standardization. The number of 
principal components as assessed by PCA is less than or equal to the 
number of original variables. This transformation is defined in such a 
way that the first principal component had as high a variance as 
possible.  
Scores plot and loadings plot of the “untreated” yeast extract batches A 
and D are reported below (Fig. 3). Yeast extract batches can be 
distinguished, but the loadings plot is noisy: the biggest difference is 
related to water content. 
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Fig. 3. SIMCA elaboration of the spectra acquired for lots A and D. In the 
scores plot (upper panel) batch A and D are respectively represented with 
green and red colors. The loadings plot (lower panel) batch A and D are 
respectively represented with black and red colors. 
 
Scores plot and loadings plot of the freeze dried yeast extract batches A 
and D are reported below (Fig. 4). Yeast extract batches can be 
distinguished even in this case. Yeast batch A (green/black) shows the 
biggest difference to be in the NH and OH functional groups with respect 
to yeast B, which shows differences in water content.  
 
   115 
 
Sergio Pirato – PhD Thesis 
 
 
Fig. 4. SIMCA elaboration of the spectra acquired for lots A and D. In the 
scores plot (upper panel) batch A and D are respectively represented with 
green and red colors. The loadings plot (lower panel) batch A and D are 
respectively represented with black and red colors. 
 
The qualitative results obtained for low and high yield yeast extract 
batches demonstrated the ability of this technique to distinguish yeast 
extract into 2 distinct clusters. In the case of freeze dried yeast extract 
samples can be distinguished by NH and OH functional groups.  
After the successful qualitative study, quantitative studies were carried 
out to create a predictive model which allows forecasting the yeast 
extract yield performance. 
Exploiting  Quant+ software, 5 principal components (or factors) were 
identified as the most relevant in terms of variability. These spectra were 
regressed against the values for yields obtained from large-scale 
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fermentations and matched to the corresponding protein yields. The 
regression model for each property was refined by selecting only those 
factors considered to be of statistical significance in determining that 
property. The linearity observed in the following figure confirms a good 
correlation between the yields and the  results coming from the Multiple 
Linear Regression (MLR) performed on the identified factors (Fig. 5). 
 
 
Fig. 5. Yield prediction curve built with NIR spectra of yeast extract batches 
used in manufacturing. The PCA elaboration was carried out with Quant+ 
software. 
 
This curve was used as a calibration curve, to predict yield for unknown 
yeast extract batches by plotting the acquired spectra on the curve 
(Table 1). Yield predicted for the lot F was subsequently obtained and 
analyzed (in a different session) and  not in part of the historical data. 
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Yeast 
Extract 
Predicted 
Yield (gr) 
Observed 
Yield (gr) 
Difference 
(gr) 
D 54,11 52.21 1.90 
F 
 
48.39 41.39 7.0 
C 36.91 43.66 6.75 
A 39.88 43.95 3.07 
Table 1: Predicted yield versus known yield. F batch yields data are not 
reported in figure 1. 
 
3.5 Conclusions 
A NIR Spectroscopy model has been developed to predict yeast extract 
performance in terms of protein yield. From a qualitative point of view it 
has been demonstrated how the method is suitable to distinguish high 
performing versus low performing batches. The goal of developing a 
yield prediction model has been investigated. For this kind of study the 
maximum difference accepted between experimental and predicted 
values was internally chosen to be 10 g. The overall approach has been 
demonstrated to be promising even for yield prediction. 
Out of the analyzed batches at known yield the minimal difference 
observed was 1,9 g, while the maximal difference observed was 7 g. 
The observed differences can be explained because YE samples were 
analyzed in different sessions.  
The NIR spectroscopy model provided promising results. In order to 
confirm the obtained results further analysis on other yeast extract 
batches will be performed: by increasing the number of spectra used for 
the calibration curve and better results can be obtained in case outputs 
are affected by differences in the analytical sessions. Smoothing of the 
spectra and eventually first or second derivative will be applied in order 
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to reduce the influence of particle size to readings positively impacting 
measurements. 
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Concluding Remarks 
The present Doctorate thesis consists of two parts. In the first minor 
part, a study aiming at the development of a polymeric product suitable 
for the formulation of nanoparticle drug delivery systems, was 
undertaken. The following concluding remarks can be summarized as 
follows: 
 mPEG-PLA copolymer suitable for nanocarrier formulations was 
developed both by toluene solution and bulk polymerization 
reactions, producing two diblock copolymers characterized by a 
PLA molar mass respectively of 4186 Da and 4315 Da and a 
PEG Methoxy-terminated 5000 Da thus giving almost a 
comparable constitution in terms of the two block components .  
 Polymers cytocompatibility investigated on balb/3T3 (Clone A31) 
cells provided comparable results for concentration in the range 
of 5 mg/ml. Cells morphology evaluation confirmed quantitative 
investigations of cell viability. 
 A nanoparticle systems can be developed as ready to be loaded 
with drugs and active agents independent of their hydrophilic, 
hydrophobic or amphiphilic characters standing the hybrid 
character of the prepared block copolymer samples. 
 
The second part of the Thesis was focused on studies on raw material of 
biologic origin for the improvement of fermentation bioprocesses and 
developed at Novartis Co-Siena (Italy). The main objective of this work 
was the study of raw materials, aimed at the improvement of 
fermentation processes in terms of yields and process consistency.   
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a) The results so far achieved on spiramycin fermentation allow drawing 
the following concluding remarks: 
 The investigation for the replacement of native starch with 
modified starch, in addition of solving the mixing issue, led to an 
increased spiramycin yield by 0,3 and 0,5 g/L. 
 Relating to the obtained data, it is possible also to assert that the 
performed tests provide strong evidence that the addition of trace 
element and iron solutions at the beginning of the fermentation 
does not affect strain potency in terms of spiramycin yield and 
impurities production, reducing the contamination risks 
associated with this step. 
 Corn oil consumption behaviour demonstrated the correlation of 
its consumption with microbial secondary metabolism. As such, a 
corn oil screening study has been performed with batches from 
different suppliers. This study allowed the identification of one 
batch as high performing. Spiramycin yield was increased of 
about 11 % (0,5-0,6 g/L) and the purity degree was not affected 
thus remaining well above the specification limit. 
b) The results so far achieved on yeast extract batches allow to draw the 
following concluding remarks: 
 Yeast extract variability on C.Diphtheriae fermentation has been 
found to strictly correlate with inactivated toxin yield. Studies on 
aminoacid composition demonstrated that no correlation has 
been found between YE aminoacid pattern and protein yield. 
 A NIR Spectroscopy model has been developed to predict yeast 
extract performance in terms of protein yield. From a qualitative 
point of view it has been demonstrated how the method is 
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suitable to distinguish between high performing vs low performing 
batches.  PCA statistic analysis was performed on the obtained 
data demonstrating the suitability of this approach to develop a 
yield prediction model. However, further analysis on other yeast 
extracts are needed to increase the significance of the statistic 
model. As such, better results can be obtained in case outputs 
are affected by differences in the analytical sessions.  
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